Diastereoselective Piperidine Synthesis through DDQ-Mediated Oxidative Cyclization of Enamides, N-Vinyl Carbamates, and N-Vinyl Sulfonamides by Brizgys, Gediminas J.
 Diastereoselective Piperidine Synthesis through DDQ-Mediated Oxidative Cyclization 
of Enamides, N-Vinyl Carbamates, and N-Vinyl Sulfonamides 
 
 
 
 
 
 
 
 
by 
Gediminas J. Brizgys 
B.S. in Chemistry, The Ohio State University, 2008 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
Arts and Sciences in partial fulfillment  
of the requirements for the degree of 
Master of Science 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2011 
 
 ii 
UNIVERSITY OF PITTSBURGH 
SCHOOL OF ARTS AND SCIENCES 
 
 
 
 
 
 
 
 
This thesis was presented 
 
by 
 
 
Gediminas J. Brizgys 
 
 
 
It was defended on 
August 1, 2011 
and approved by 
Dr. Dennis P. Curran, Distinguished Service Professor of Chemistry and Bayer Professor, 
Department of Chemistry 
Dr. Craig Wilcox, Professor of Chemistry, Department of Chemistry 
Thesis Director: Dr. Paul E. Floreancig, Professor of Chemistry, Department of Chemistry 
 
 
 iii 
Copyright © by Gediminas J. Brizgys 
2011 
 iv 
ABSTRACT 
The DDQ-mediated oxidative cyclization chemistry that was previously developed in our 
group for the synthesis of tetrahydropyrones from allylic and benzylic ethers has been expanded 
for use with enamides, N-vinyl carbamates, and N-vinyl sulfonamides to synthesize piperidine 
rings.  This chemistry provides a new oxidative method to generate N-acyliminium and N-
sulfonyliminium ions.  Cyclization onto the oxidatively generated α,β-unsaturated N-
acyliminium and N-sulfonyliminium ions has been performed with a variety of tethered 
nucleophiles.  The cyclization reaction suffers no difficulties in regards to chemoselectivity or 
over oxidation.  Moreover, the resulting unit of unsaturation in the products provides an 
additional synthetic handle not generated through more classical iminium ion chemistry. 
 
Significantly, stereocontrol in the reaction was achieved through the use of (E)- and (Z)-
allylsilanes and silyl enol ethers.  Transition state models were formulated through information 
obtained from studies of monocyclic and bicyclic compounds synthesized through the oxidative 
cyclization reaction. 
Diastereoselective Piperidine Synthesis through DDQ-Mediated Oxidative Cyclization 
of Enamides, N-Vinyl Carbamates, and N-Vinyl Sulfonamides 
Gediminas J. Brizgys, M.S. 
University of Pittsburgh, 2011
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Finally, the reaction was made catalytic through regeneration of DDQ via oxidation of 
the DDQ byproduct by Mn(OAc)3.  This chemistry provides a powerful new method for 
generating nitrogen heterocycles and will provide new ways of accessing alkaloids. 
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1.0  DIASTEREOSELECTIVE PIPERIDINE SYNTHESIS THROUGH DDQ-
MEDIATED OXIDATIVE CYCLIZATION OF ENAMIDES, N-VINYL CARBAMATES, 
AND N-VINYL SULFONAMIDES 
1.1 INTRODUCTION 
1.1.1 HISTORY OF THE DDQ OXIDATIVE CYCLIZATION REACTION 
The Floreancig group has long been interested in electron-transfer initiated cyclization 
(ETIC) reactions as a method for oxidatively forming cyclic structures.  Some of the methods 
developed in the group include the use of light with N-methyl quinolinium hexafluorophosphate 
(NMQPF6)
1
 and the use of ceric ammonium nitrate (CAN).
2
  These methodologies have led to 
the total syntheses of various natural products.
3,4
  In exploring new ways to perform ETIC 
reactions, the ability of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (Figure 1) to activate 
benzylic positions through oxidative C-H bond cleavage
5
 became of interest. 
 
Figure 1: Structure of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). 
Xu and coworkers reported the oxidative C-H activation of isochroman substrates with 
DDQ (Table 1).
6
  Isochroman substrate 1.1 in DCM was treated with DDQ at room temperature 
 2 
to generate oxocarbenium ion intermediate 1.2.  The intermediate was reacted with a variety of 
nucleophiles to provide isochroman derivative 1.3 in good yield.  High trans-selectivity was 
reported with 3-substituted isochroman substrates.  This chemistry was ultimately used in Xu’s 
total synthesis of deoxyfrenolicin.
7
 
Table 1: DDQ-mediated oxidation of isochroman substrates. 
 
 Xu and coworkers then expanded this chemistry to acyclic benzyl ethers containing 
electron-rich arenes (Table 2).
8
  Lithium perchlorate (LiClO4) was found to greatly improve the 
yield of the reaction, presumably due to the perchlorate ion undergoing ion exchange with the 
charge transfer complex.  This newly generated ion pair serves as a better electrophile than the 
initial charge transfer complex.  Unactivated benzyl ethers provided no product.  Xu claims that 
the electron-donating substituents act to stabilize the intermediate benzylic oxocarbenium ion, 
and their absence prevents the initial hydrogen abstraction. 
 3 
Table 2: DDQ-mediated oxidation of acyclic benzyl ethers. 
 
 Studies by Mukaiyama demonstrated that allylic ethers react in a similar fashion, with 
phenyl-substituted allylic ethers reacting more efficiently than alkyl substituted ones (Table 3).
9
  
Once again, LiClO4 was required to increase yield.  The nucleophiles used were incompatible 
with DDQ, thus requiring the addition of excess nucleophile only after DDQ was stirred with the 
allylic ether for one hour to ensure complete conversion to the intermediate oxocarbenium ion.  
The persistence of the oxocarbenium ion during this reaction speaks to its stability.  This 
stability, however, resulted in lower reactivity and limited the scope of reactive nucleophiles. 
Table 3: DDQ-mediated oxidation of acyclic allylic ethers. 
 
 4 
 The Floreancig group expanded this DDQ oxidative C-H activation chemistry.  Tethering 
the nucleophile to the benzylic or allylic ether provided a method for diastereoselective 
tetrahydropyrone synthesis with good functional group compatibility.
10
  A variety of arenes were 
tested with the enol acetate nucleophile.  The enol acetate nucleophile was chosen because it acts 
as a latent enolate while also being easy to purify and handle.  In the presence of 2,6-
dichloropyridine and activated, powdered 4 Å mol. sieves, a variety of tetrahydropyrones were 
obtained in high yield and with a 2,6-cis relationship between ring substituents (Table 4).  The 
cyclization reaction was also compatible with allylic ethers, provided that 0.1 equiv. of LiClO4 
was added prior to DDQ addition. 
Table 4: DDQ-mediated oxidative cyclization to form tetrahydropyrones. 
 
 The proposed mechanism for this reaction is shown in Scheme 1.  Benzyl ether 1.4 
undergoes one-electron oxidation to form radical ion pair 1.5, which then undergoes either direct 
hydrogen atom abstraction or a two-step process involving proton abstraction followed by single-
electron oxidation by the reduced DDQ, yielding oxocarbenium ion intermediate 1.6.  
Cyclization then occurs, proceeding through the depicted chair conformation of 1.6, to give 2,6-
cis tetrahydropyrone 1.7.  Following development, this chemistry was used by the Floreancig 
group for the total synthesis of neopeltolide and analogs.
11,12
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Scheme 1: Proposed mechanism of DDQ-mediated oxidative cyclization with benzyl ethers. 
The chemistry was further developed to provide structurally and stereochemically diverse 
tetrahydropyrans.
13
  2,6-cis and 2,6-trans tetrahydropyrones were obtained through oxidation of 
propargylic ethers.  The small difference in A-value between hydrogen and an alkyne allowed 
for formation of both (Z)- and (E)-oxocarbenium ions.  From these tetrahydropyrones, eight 
different stereoisomers were created through stepwise stereoselective reduction of the ketone, 
hydrosilation of the alkyne, and stereoselective reduction of the resulting vinyl silanes (Figure 2).  
Oxidation of the silanes under Tamao conditions and, if necessary, silyl ether cleavage converted 
the silanes to alcohols. 
 6 
 
Figure 2: Structurally and stereochemically diverse products from the DDQ oxidative cyclization reaction. 
 With the success of the allylic and benzlic ethers, the ability of more easily oxidized N-
vinyl oxazolidinones to participate in this chemistry was explored.  N-vinyl oxazolidinones were 
expected to serve as excellent precursors for α,β-unsaturated N-acyliminium ions.  In the 
presence of 4 Å mol. sieves, 2 equiv. of 2,6-dichloropyridine, 0.15 equiv. of LiClO4, and 2 equiv. 
of DDQ, the desired cyclization took place to form a variety of carbocycles in good yield and 
with good stereocontrol (Table 5).
14
 
 7 
Table 5: DDQ-mediated oxidative cyclization with N-vinyl oxazolidinones. 
 
 With the success of this chemistry in forming the highly electrophilic N-acyliminium ion, 
the formation of piperidine rings through DDQ-mediated oxidative cyclization was an attractive 
extension. 
1.1.2 THE N-ACYLIMINIUM ION 
The iminium ion is a cationic species that has long been used for the formation of carbon-
carbon bonds, both in an intermolecular and an intramolecular fashion.  The ability to introduce 
nitrogen and generate N-heterocycles is of great importance given the plethora of alkaloid natural 
products.
15
  Noteable reactions that proceed through an iminium intermediate include: 
1) The Mannich reaction, in which an in situ generated enolate or a latent enolate reacts 
with an iminium ion.
16
 
 8 
2) The Pictet-Spengler reaction, in which an iminium ion is generated from 
condensation of a β-arylamine with a ketone or aldehyde with subsequent attack from 
the β-aryl group.17 
Sometimes, however, the iminium ion proves to be insufficiently electrophilic.  This can 
often be resolved through the addition of an electron withdrawing group, such as an acyl group, 
to the iminium ion.  The resulting N-acyliminium ion possesses increased electrophilicity, 
broadening the range of nucleophiles that can be used.
18 
Due to their increased reactivity, N-acyliminium ions are almost always generated in 
situ.
18
  There are five main methods that have been used to generate N-acyliminium ions.
18
  
These methods are acylation of N-substituted imines (A), electrophilic addition to N-acyl imines 
(B), electrophilic addition to enamides (C), heterolysis (D), and oxidation of amides at the α 
carbon (E) (Figure 3). 
 
Figure 3: Methods for accessing N-acyliminium ions. 
N-substituted imines are readily accessible via condensation of aldehydes or ketones with 
primary amines.
19
  Subsequent treatment with an acid halide or anhydride produces the desired 
 9 
N-acyliminium ion.  An interesting reaction with this style of N-acyliminium ion formation was 
developed by Castagnoli and Cushman
20,21
 and later used by Cushman and co-workers in their 
synthesis of corynoline (Scheme 2).
22
  Cyclic anhydride 1.8 was reacted with imine 1.9 to form 
N-acyliminium ion intermediate 1.10.  The carboxylate anion in 1.10 is in equilibrium with acid 
enolate 1.11, the reactive species in this sequence, which attacks the N-acyliminium ion to 
provide amide 1.12.  1.12 was carried on to synthesize corynoline. 
 
Scheme 2: Key step involving N-acyliminium ion chemistry in the synthesis of corynoline. 
 Electrophilic addition to N-acyl imines often involves simple protonation or alkylation of 
the N-acyl imine to provide the N-acyliminium ion (Scheme 3).  Reaction with a suitable 
nucleophile can then be performed. 
 
Scheme 3: Electrophilic addition to N-acyl imine. 
 Enamides are a useful product derived from N-acyliminium ions.  They result from the 
abstraction of a proton at the carbon β to the nitrogen.  However, as the synthetic utility of these 
compounds continues to grow, catalytic methods are emerging that allow for direct access to 
enamides via coupling reactions.
23,24,25
  Enamides can react with an electrophile to provide the N-
 10 
acyliminium ion.  The resulting N-acyliminium ion can be trapped with a nucleophile or 
tautomerize to generate the enamide once more.  This type of chemistry is seen in the reaction of 
isoquinoline enamides developed by Lenz and Woo (Scheme 4).
26
  N-vinyl carbamate 1.13 was 
reacted with isocyanate ester 1.14 to give N-acyliminium ion intermediate 1.15.  Subsequent 
proton transfer provided N-vinyl carbamate 1.16. 
 
Scheme 4: Electrophilic addition to an enamide. 
 Heterolysis is perhaps the most often used and most diverse method of generating N-
acyliminium ions.  Leaving groups on the carbon α to the nitrogen can be halogen, nitrogen, 
sulfur, or phosphorous based, but a large majority of these reactions involve Brønsted or Lewis 
acid catalysis of α-oxyalkyl amides.18  Notably, if the group bound to the α-oxy is acetyl or 
methanesulfonyl, catalyst is often unnecessary.
27,28
  Scheme 5 shows an example of both 
Brønsted and Lewis acid catalysis being used.  Glutarimide is partially reduced with NaBH4 and, 
upon acidic workup in ethanol, proceeds through N-acyiminium ion intermediate 1.17 to give 
1.18.
29
  Treatment of 1.18 with BF3∙OEt2 again generates N-acyliminium ion 1.17, which is 
reacted with allenyltributyltin to provide amide 1.19. 
 11 
 
Scheme 5: Brønsted and Lewis acid catalyzed generation of N-acyliminium ions. 
Similarly, N-acyliminium ions can be generated in a single pot by condensation of aldehydes and 
ketones with secondary amides under acidic conditions.  The reaction initially forms an α-
hydroxyalkyl amide which, under the acidic conditions, undergoes dehydration to provide the N-
acyliminium ion (Scheme 6). 
 
Scheme 6: Condensation of an amide with an aldehyde under acidic conditions to provide an N-acyliminium ion. 
Finally, oxidation at the carbon α to the amide nitrogen is a method for N-acyliminium 
ion formation.  This can be performed electrochemically, where the oxidized intermediate is 
often trapped by an alcohol for later use.
30
  In addition, N-acyliminium ions can be generated via 
chemical oxidation.  Examples include ruthenium-catalyzed oxidation of amides,
31
 the use of 
hypervalent iodide to install an azide moiety,
32
 and oxidation by Cu
2+
 following formation of an 
α-amidyl radical.33  With chemical methods, however, there can be problems with regiocontrol 
and overoxidation.
34
 
N-acyliminium ions have been successfully reacted with a wide variety of π-nucleophiles, 
including alkenes, alkynes, and aromatics (Table 6).
18,34
  This has made the N-acyliminium ion 
powerful in the synthesis of alkaloid natural products
35
 and unique nitrogen heterocycles.  With 
this utility, the usefulness of expanding the previously developed DDQ oxidative cyclization 
 12 
chemistry to enamides and N-vinyl carbamates for N-heterocycle formation is apparent.  DDQ 
oxidation of the enamide or N-vinyl carbamate would provide a new, mild chemical method for 
N-acyliminium ion generation for the production of N-heterocycles.  It would also provide an 
additional functional handle through the resulting β,γ unsaturation. 
Table 6: Examples of π-nucleophiles reacted with N-acyliminium ions. 
 
1.2 DDQ-MEDIATED OXIDATIVE CYCLIZATION WITH ENAMIDES AND N-
VINYL CARBAMATES 
1.2.1 DEVELOPMENT OF THE OXIDATIVE DDQ CYCLIZATION REACTION 
Former group member Hyung Hoon Jung developed the reaction conditions for the 
oxidative DDQ cyclization chemistry for the synthesis of nitrogen heterocycles.  An enamide 
was initially chosen as the moiety to be oxidized, and a tethered enol acetate was chosen as the 
nucleophile.  The precursor was synthesized as shown in Scheme 7.  3-Butyn-1-ol was converted 
to 3-butyn-1-amine 1.20 through mesylation, displacement of the mesylate by sodium azide, and 
reduction of the resulting azide.  Reaction of amine 1.20 with acetic anhydride furnished the 
amide, and condensation of the amide with heptanal under acid catalyzed conditions yielded 
 13 
enamide 1.21.  Ruthenium catalyzed Markovnikov addition of acetic acid across the alkyne 
provided enol acetate 1.22.
36
 
 
a) MsCl, NEt3, Et2O. b) NaN3, DMF, 70 ˚C. c) PPh3, H2O. d) Ac2O, Et2O. e) Heptanal, PTSA, 
C6H6, reflux, 8%, five steps. f) Na2CO3, [(p-cymeme)RuCl2]2, (Fur)3P, HOAc, 1-decyne, PhMe, 
80 ˚C, 83%. 
 
Scheme 7: Synthesis of enamide to test the DDQ oxidative cyclization reaction. 
 Initial attempts to cyclize enol acetate 1.22 under the conditions used for the allylic and 
benzylic ethers (see Table 4, p. 4) were unsuccessful, providing only undesired α,β-unsaturated 
enamide 1.26 (Table 7).  A more polar solvent was proposed to stabilize the N-acyliminium ion 
intermediate, preventing this undesired side reaction.  A screen of conditions by Mr. Jung 
quickly identified nitromethane to be an ideal solvent for the reaction.  The reaction was found to 
proceed best at room temperature with 1.5 equiv. of DDQ and 1 mass equiv. of 4 Å mol. sieves.  
The 2,6-dichloropyridine and LiClO4 additives, while integral to the DDQ oxidative cyclization 
with allylic and benzylic ethers, were found to be unnecessary in the reaction with enamides 
under these conditions.  Methyl carbamate precursor 1.23 was also synthesized and was found to 
provide higher yield (82%) under the optimized conditions.  Carbamates also provide products 
that can undergo valuable transformations, such as acidic cleavage and reduction to methyl 
amines (see Scheme 18, p. 25).  Given all of these benefits, N-vinyl carbamates were chosen as 
the oxidizable moiety to pursue with a majority of the development. 
 14 
Table 7: Conditions screened for the DDQ oxidative cyclization reaction. 
 
1.2.2 PROPOSED MECHANISM OF THE OXIDATIVE DDQ CYCLIZATION 
REACTION WITH ENAMIDES AND N-VINYL CARBAMATES 
The proposed mechanism (Scheme 8) is similar to the mechanism proposed for the 
reaction of vinyl and benzyl ethers (see Scheme 1, p. 5).  Enamide or N-vinyl carbamate 1.28 
undergoes one-electron oxidation by DDQ to form radical N-acyliminium ion 1.29 which then 
undergoes either direct hydrogen atom abstraction by DDQ or a two-step process involving 
proton abstraction followed by single-electron oxidation by DDQ to generate α,β-unsaturated N-
acyliminium ion 1.30.  Nucleophilic attack by the tethered enol acetate provides piperidinone 
1.31. 
 15 
 
Scheme 8: Proposed mechanism for the DDQ-mediated oxidative cyclization with enamides and N-vinyl carbamates. 
1.2.3 OPTIMIZED SYNTHESIS OF THE N-VINYL CARBAMATE 
After Mr. Jung developed the optimized reaction conditions, we looked to expand the 
scope of the oxidative cyclization reaction.  An optimized route was employed for the synthesis 
of N-vinyl carbamates for the continued study of the cyclization chemistry (Scheme 9).  The 
general synthesis began with primary alcohol 1.32 which was converted to the mesylate.  
Reaction with NaN3 afforded the azide which was reduced to amine 1.33 with LiAlH4.  Amine 
1.33 was reacted with ethyl chloroformate to give the secondary carbamate which underwent a 
condensation reaction with heptanal using catalytic PTSA or PPTS to give desired N-vinyl 
carbamate 1.34. 
 
a) MsCl, NEt3, Et2O. b) NaN3, DMF, 70 ˚C. c) LiAlH4, 
Et2O. d) ClCO2Et, NEt3, Et2O. e) Heptanal, PTSA or 
PPTS, C6H6, reflux. 
Scheme 9: General synthesis of N-vinyl carbamates. 
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Various challenges were encountered during the condensation step to form N-vinyl 
carbamate 1.34.  The reaction often gave lower than desired conversion.  However, no 
decomposition of starting material was observed, and yields were consistently over 90% by 
recovered starting material.  Difficulties also arose if the condensation was performed with 
stronger nucleophiles in place.  As previously discussed, the N-acyliminium ion is an 
intermediate in the reaction to form the N-vinyl carbamate (see Scheme 6, p. 11).  Nucleophiles 
that are already tethered in place possess the ability to cyclize on this N-acyliminium ion.  The 
undesired cyclized byproduct was limited through carefully controlling the temperature of the oil 
bath during the condensation reaction.  If the temperature of the oil bath was maintained in the 
low 90 ˚C range, N-vinyl carbamate was the dominant or exclusive product.  If the temperature 
rose towards 100 ˚C, mostly cyclized product was obtained.  The temperature necessary to enact 
cyclization on the N-acyliminium ion is likely a direct reflection on nucleophilicity of the 
nucleophile used. 
1.2.4 SYNTHESIS AND TESTING OF NUCLEOPHILES IN THE DDQ OXIDATIVE 
CYCLIZATION REACTION 
A number of π-nucleophiles have been reported to cyclize onto the N-acyliminium ion.18  
Encouraged by the result of the enol acetate as a nucleophile, we began expanding the scope of 
tethered nucleophiles.  Initial results were, disappointing.  Attempts at the oxidative cyclization 
reaction with vinyl silane, furan, and 3-methoxy benzene as nucleophiles were unsuccessful, 
leading only to decomposition of the starting material.  Based on these results, we proposed that, 
under the reaction conditions, it may be kinetically favorable to have a bond breaking at the same 
time that the key carbon-carbon bond is forming (Scheme 10).  With the enol acetate, for 
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example, the bond between the sp
3
 hybridized oxygen and the carbonyl carbon breaks to release 
the acylium ion.  To test this hypothesis, allylsilanes, silyl enol ethers, and propargylic silane 
were synthesized. 
 
Scheme 10: Unfavorable oxidative cyclization reaction with sequential bond forming and breaking and favorable 
reaction with concerted bond forming and breaking. 
 The general method employed for the synthesis of (E)-allylsilane nucleophiles is shown 
in Scheme 11.  Treatment of terminal alkyne 1.35 with Schwartz’s reagent, generated in situ by 
treatment of zirconocene dichloride with DIBALH
37
 and quenching with molecular iodine 
provided (E)-vinyl iodide 1.36 exclusively.  Kumada coupling of the vinyl iodide and 
(trimethylsilyl)methylmagnesium chloride by Pd(PPh3)4 provided desired (E)-allylsilane 1.37.
38
 
 
Scheme 11: Syntheis of the (E)-allylsilane nuclophile. 
The general method employed for the synthesis of (Z)-allylsilane nucleophiles is shown 
in Scheme 12.  Deprotonation of terminal alkyne 1.38 and reaction with iodomethyl 
trimethylsilane provided propargylic silane 1.39.  Initial reduction of the alkyne to (Z)-alkene 
1.40 was performed using Lindlar’s catalyst under positive H2 pressure.  This, however, 
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generated an inseparable mixture of (E)- and (Z)- isomers and led to some over reduction.  
Reduction via P2 nickel provided (Z)-allylsilane 1.40 exclusively and avoided issues with over 
reduction.
39
 
 
Scheme 12: Synthesis of the (Z)-allylsilane nucleophile. 
Preparation of the (E)- and (Z)-silyl enol ethers, 1.43 and 1.44 respectively, began with 
Parikh-Doering oxidation of alcohol 1.41 to aldehyde 1.42 (Scheme 13).
40
  The aldehyde and 
NEt3 were then added to TESCl and NaBr in DMF to generate the enolates and trap them as silyl 
enol ethers.
41
  The products were generated with an E:Z ratio of 1:2.4.  The stereoisomers were 
separated by medium-pressure liquid chromatography.  TMS and TIPS were also tested for 
enolate trapping.  The TMS silyl enol ether was unstable to silica and not able to be purified to 
an appropriate level.  Reaction with TIPSCl proved slow, with only trace amounts of product 
formed after 48 h. 
 
Scheme 13: Synthesis of the silyl enol ether nucleophiles. 
All of these nucleophiles successfully participated in the DDQ-mediated oxidative 
cyclization reaction (Table 8).  Propargylic silane 1.51 provided allene product 1.52.  The 
allylsilanes and silyl enol ethers reacted similarly, providing their respective 2,3-substituted 
piperidines.  These nucleophiles were also found to provide diastereocontrol in the cyclization 
reaction.  (E)-Allylsilane 1.47 provided 2,3-trans piperidine 1.48 exclusively.  (E)-Silyl enol 
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ether 1.43 also provided the 2,3-trans piperidine, 1.53, but with decreased stereocontrol at 6.7:1 
dr.  (Z)-Allylsilane 1.49 gave 2,3-cis piperidine 1.50 preferentially at 3.3:1 dr.  Similarly, (Z)-
silyl enol ether 1.44 yielded 2,3-cis piperidine 1.54 but with lower stereoselectivity at 2.7:1 dr. 
Table 8: Results from the DDQ-mediated oxidative cyclization of N-vinyl carbamates. 
 
Reaction Conditions: DDQ (1.5 equiv.) was added in one portion to 
a stirred solution of precursor and 4 Å M.S. (1 mass equiv.) in DDQ 
(~0.1 M solution of precursor).  After 3 min., the reaction mixture 
was quenched with NEt3 and directly purified by silica gel 
chromatography (see experimental section for column conditions). 
a Yields refer to purified, isolated yields and a mixture of 
stereoisomers where appropriate. 
b dr determined via NMR. 
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1.2.5 SYNTHESIS OF BICYCLIC SYSTEMS VIA DDQ OXIDATIVE CYCLIZATION 
The synthesis of bicyclic systems was then pursued to expand the complexity of the 
products and gain insight into the stereocontrol exhibited by the reaction.  Synthesis of enol 
acetate precursors 1.61 and 1.62 began with mono-reduction of succinimide (1.55) or glutarimide 
(1.56) followed by acidic workup in ethanol to give α-alkoxy amides 1.57 and 1.58 (Scheme 14).  
Treatment of lactams 1.57 and 1.58 with BF3∙OEt2 and allenyltributyltin gave desired alkynes 
1.59 and 1.60.  Enol-acetate precursors 1.61 and 1.62 were synthesized by condensation of 1.59 
and 1.60 with heptanal followed by Markovnikov addition of acetic acid to the alkyne as 
previously described (see Scheme 7, p. 13). 
 
Scheme 14: Synthesis of enol acetate precursors for [3.4.0] and [4.4.0] bicycles. 
 Allylsilane precursors were synthesized next (Scheme 15).  (E)-Allylsilane fragment 1.63 
was synthesized by the method previously described (see Scheme 11, p. 17).  Conversion of 
alcohol 1.63 to Grignard 1.64, addition to glutarimide, and subsequent deoxygenation provided 
lactam 1.65.  Interestingly, condensation with heptanal, as performed many times before, did not 
occur with 1.65.  A screen of catalytic conditions revealed a copper iodide catalyzed coupling of 
the cyclic amide with (E)-1-iodo-hex-1-ene to successfully generate enamide 1.66.
25
  (Z)-
Allylsilane precursor 1.69 was prepared by a similar sequence in which propargylic silane 1.67, 
formed by reaction of propargyl trimethylsilane and 2-iodo-ethanol,
42
 was used in place of 1.63.  
Propargylic silane 1.68 was then reduced with P2 nickel to give (Z)-allylsilane precursor 1.69. 
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Reaction Conditions: a) PPh3, Br2, Pyridine, DCM, 0 ˚C, 69%; 69%. b) Mg
0, THF, reflux. c) glutarimide, 
0 ˚C. d) NaCNBH3, HOAc, 41% over three steps; 13% over three steps. e) (E)-1-iodo-hex-1-en, CuI, N,N’-
dimethylethylenediamine, Cs2CO3, THF, 110 ˚C, 11%; 10%. f) Ni(OAc)2·4H2O, NaBH4, EtOH, H2, 
ethylenediamine, 87%. 
Scheme 15: Synthesis of allylsilane precursors for [4.4.0] bicycles. 
The lactam-derived substrates were then subjected to the oxidative cyclization conditions 
and provided their respective [3.4.0] or [4.4.0] bicycles (Table 9).  Allylsilanes 1.66 and 1.69 
gave markedly higher yields in the DDQ oxidative cyclization reaction with N-vinyl lactams 
compared with their linear N-vinyl carbamate counterparts (see Table 8, p. 19, entries 2 and 3 
and Table 9, p. 22, entries 3 and 4).  This is likely due to the decreased degrees of freedom 
experienced by the nucleophiles, allowing them to spend more time in a geometry that is 
compatible with cyclization.  Also noteworthy is that the allylsilane nucleophiles produced the 
same stereochemical outcome with N-vinyl lactams as with N-vinyl carbamates. 
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Table 9: Results from the DDQ-mediated oxidative cyclization to form bicyclic systems. 
 
Reaction Conditions: DDQ (1.5 equiv.) was added in one portion to 
a stirred solution of precursor and 4 Å M.S. (1 mass equiv.) in DDQ 
(~0.1 M solution).  After 3 min., the reaction mixture was quenched 
with NEt3 and directly purified by silica gel chromatography (see 
experimental section for column conditions). 
a Yields refer to purified, isolated yields and a mixture of 
stereoisomers where appropriate. 
b dr determined via NMR. 
1.3 DDQ-MEDIATED OXIDATIVE CYCLIZATION WITH N-VINYL 
SULFONAMIDES 
With positive results from enamides and N-vinyl carbamates, we looked to expand the 
oxidative cyclization chemistry to N-vinyl sulfonamides.  The N-vinyl sulfonamides were easily 
accessed through the chemistry described in section 1.2.3 (p. 15), wherein the appropriate 
chlorosulfonamide was used in place of ethyl chloroformate.  Condensation with heptanal to 
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form the N-vinyl sulfonamide proceeded smoothly and was less sensitive to temperature than 
with the corresponding N-vinyl carbamates, presumably due to the intermediate N-
sulfonyliminium ion being less stable and more rapidly undergoing deprotonation to form the N-
vinyl sulfonamide.  Nucleophiles were synthesized as described in section 1.2.4 (p. 16). 
The N-vinyl sulfonamides were found to be compatible with the reaction conditions 
developed for the N-vinyl carbamates (Table 10).  Enol acetate precursors 1.74 and 1.80 cyclized 
onto N-vinyl methanesulfonamide and N-vinyl p-toluenesulfonamide, providing desired 
piperidines 1.75 and 1.81 in 69% and 64% yields respectively.  The allylsilanes, however, 
initially provided low yields and many decomposition products under the same conditions.  
Adding one equiv. of LiClO4 resulted in much higher yields and a very clean reaction.  
Interestingly, the stereochemical outcome for the major product from the allylsilanes was 
opposite that observed when using N-vinyl carbamates.  (E)-Allylsilane 1.76 provided piperidine 
1.77 with 2,3-cis ring substituents with a 3.7:1 dr, while (Z)-allylsilane 1.78 provided piperidine 
1.79 with 2,3-trans ring substituents with a 2.7:1 dr.  Use of (E)-allylsilane 1.82 with p-
toluenesulfonamide in place of methanesulfonamide produced piperidine 1.83 with a negligible 
change in dr. 
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Table 10: Results from the DDQ-mediated oxidative cyclization of N-vinyl sulfonamides. 
 
Reaction Conditions: DDQ (1.5 equiv.) was added in one 
portion to a stirred solution of precursor and 4 Å M.S. (1 mass 
equiv.) in DDQ (~0.1 M solution).  After 3 min., the reaction 
mixture was quenched with NEt3 and directly purified by silica 
gel chromatography (see experimental section for column 
conditions). 
a Yields refer to purified, isolated yields and a mixture of 
stereoisomers where appropriate. 
b dr determined via NMR. 
c 1 equiv. of LiClO4 was added prior to DDQ addition. 
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1.4 STEREOCHEMISTRY IN THE DDQ OXIDATIVE CYCLIZATION 
Initial attempts at controlling stereochemistry pursued chemistry analogous to what had 
been done in the cyclization of benzylic and allylic ethers (see Table 4, p. 4).  The thought was 
that a product with 1,5 substitution would have proceeded through a preferential transition state, 
giving diastereocontrol (Scheme 16).  Additionally, enantio-enriched enol acetate precursor 1.86 
could be formed through chemistry developed by Ellman.
43
  Disappointingly, N-vinyl carbamate 
1.85 could not be synthesized.  Condensation with carbamate 1.84 is believed to have failed due 
to steric interactions in the transition state.  Attempted catalytic methods for N-vinyl carbamate 
formation from this acyclic system failed. 
 
Scheme 16: Failed route for stereocontrol by synthesis of 2,6-substituted piperidines. 
A second attempt involved using a chiral chloroformate to create a chiral N-vinyl 
carbamate (Scheme 17).  Although the DDQ-mediated cyclization took place cleanly, a 1:1 
mixture of diastereomers was obtained from the reaction.  Separation was not attempted. 
 
Scheme 17: Attempt at stereocontrol using a chiral carbamate. 
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We were excited to find that the (E)- and (Z)-allylsilanes and silyl enol ethers provided 
different diastereomers as major products.  The stereochemistry of the allylsilane-derived 
products could not be determined as carbamates since the ring structures did not assume rigid 
conformations.  The substituent at the 2-position is, however, expected to assume an axial 
orientation to alleviate A-strain.  Reduction of the carbamates to the methyl amines allowed for 
the rings to assume more rigid chair conformations.  COSY analysis then allowed for 
identification of the key hydrogen peaks, and coupling constant analysis allowed the relative 
stereochemistry between the hydrogens on the 2 and 3 positions to be determined (Scheme 18).  
The 9.0 Hz coupling constant observed in N-methyl piperidine 1.87 indicates a dihedral angle 
nearing 0º or 180º and a 2,3-trans relationship between the ring substituents.  The 3.4 Hz 
coupling constant observed in N-methyl piperidine 1.88 indicates a near-90º dihedral angle and a 
2,3-cis configuration of ring substituents.  The stereochemistry of the silyl enol ether products 
was identified by comparison of their spectra with that of the allylsilane products. 
 
Scheme 18: Reduction of carbamates and determination of stereochemistry of 2,3-substituted piperidines. 
This outcome was unexpected.  We anticipated that both substituents would assume the 
equatorial positions in the transition state, thus giving the 2,3-trans products from both starting 
materials (Figure 4). 
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Figure 4: Initially proposed transition states for the allylsilanes with enamides and N-vinyl carbamates. 
The bicyclic systems provided valuable information to elucidate the geometry of the 
transition state.  NOESY analysis of 1.71 revealed an interaction between the hydrogens as 
shown in Figure 5.  This interaction can only occur given the product geometry as shown.  It can 
then be concluded that the cyclization occurs through the transition state geometry shown in 
Figure 5, with an s-cis configuration of the N-acyliminium ion and the C=N bond having (E)- 
geometry.  The s-cis configuration of the N-acyliminium ion has been calculated to be more 
stable than the s-trans.
44,45
  The (E)- geometry around the C=N iminium bond is proposed to 
occur due to stabilization of the N-acyliminium ion through non-traditional hydrogen bonding 
between the carbonyl oxygen and the iminium hydrogen as indicated. 
 
Figure 5: Transition state and product for [4.4.0] bicycle. 
Knowing the geometry of the N-acyliminium ion in the transition state identified the 
configuration of the allylsilane and silyl enol ether nucleophiles in the transition state.  The (E)- 
nucleophiles preferentially assume an axial position in the transition state (Figure 6).  This 
allows the carbonyl oxygen to help stabilize the building positive charge on the nucleophile as 
the electrofuge leaves.  The s-cis configuration of the N-acyliminium ion facilitates this 
stabilizing effect.  The decrease in selectivity observed from (E)-silyl enol ether 1.43 (see Table 
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8, p. 19, entry 5) compared with (E)-allysilane 1.47 (see Table 8, p. 19, entry 2) may arise from 
stabilization by the ether oxygen decreasing the energetic benefit gained from interaction of the 
nucleophile with the carbonyl oxygen.  In addition, greater reactivity and an earlier transition 
state may limit the interaction between the carbonyl oxygen and the silyl enol ether.  These 
variations allow for some 2,3-cis product 1.54 to be generated from the (E)-silyl enol ether. 
 
Figure 6: Proposed transition state for the (E)-allylsilane explaining observed results. 
An axial orientation of the nucleophile in (Z)- systems generates unfavorable steric 
interactions.  The nucleophile instead assumes the energetically favorable equatorial position to 
generate the major product, 2,3-trans piperidine 1.50 (Figure 7).  This may partially account for 
the higher yield of cyclized product resulting from the (Z)-allylsilane (91%) compared with the 
(E)-allylsilane (65%), as it proceeds through an anti-periplanar transition state.  This transition 
state, however, suffers from a developing unfavorable syn-pentane interaction, bolded in Figure 
7.  Generation of the minor product, 2,3-trans piperidine 1.48, may result from the nucleophile 
taking the axial position in the transition state (A), a boat transition state (B), or the C=N bond of 
the N-acyliminium ion assuming (Z)- geometry (C).  The results from the bicyclic systems favor 
the boat transition state for the (Z)-allylsilane and disfavor (C) while steric interactions disfavor 
(A).  The decreased stereoselectivty observed with (Z)-silyl enol ether 1.44 likely results from 
enhanced nucleophilicity and an earlier transition state for the (Z)-silyl enol ether compared with 
the (Z)-allylsilane.  The resulting steric interactions in transition state A in Figure 7 are less 
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influential for (Z)-silyl enol ether 1.44, allowing more of the minor 2,3-trans product to form 
through that transition state geometry. 
 
Figure 7: Proposed transition states and resulting products for the (Z)-allylsilane. 
The stereochemistry of the methanesulfonyl piperidines was easier to determine due to 
the products possessing more rigid ring structures.  The key hydrogen at the 2-position provides 
clear evidence of the relative stereochemistry of the ring substituents (Figure 8).  The coupling 
constant between the hydrogens at the 2 and 3 positions in 2,3-cis piperidine 1.77 is so small that 
it is not observed in the 
1
H NMR spectrum.  The coupling constant between the hydrogens at the 
2 and 3 positions of piperidine 1.79 was found to be 4.9 Hz, confirming the trans relationship 
between the ring substituents and a diaxial orientation of the substituents, presumably to alleviate 
A-strain. 
 
Figure 8: Determination of stereochemistry for sulfonyl piperidines. 
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Interestingly, while the (E)-allylsilane nucleophile generated exclusively 2,3-trans 
piperidine 1.48 from N-vinyl carbamate 1.47 (see Table 8, p. 19, entry 2), 2,3-cis piperidines 
1.77 (3.7:1 dr) and 1.83 (4.0:1 dr) were obtained preferentially from N-vinyl 
methanesulfonamide 1.76 and N-vinyl p-toluenesulfonamide 1.82 respectively with the same 
nucleophile (see Table 10, p. 24, entries 2 and 5).  Similarly, while the (Z)-allylsilane nucleophile 
preferentially gave 2,3-cis piperidine 1.50 (3.3:1 dr) from N-vinyl carbamate 1.49 (see Table 8, 
p. 19, entry 3), 2,3-trans piperidine 1.79 (2.7:1 dr) was the major product with N-vinyl 
sulfonamide 1.78 and the same nucleophile (see Table 10, p. 24, entry 3).  This suggests that the 
sulfonamide does not provide the same stabilization of the nucleophiles that the carbamate and 
amide do.  Steric interactions are believed to be the driving force for stereocontrol with these 
compounds.  The proposed transition states leading to the observed products are shown in Figure 
9.  Since bicyclic systems were not synthesized from N-vinyl sulfonamides, the possibility of the 
C=N bond of the sulfonyliminium ion assuming the (Z)- geometry cannot be ruled out. 
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Figure 9: Proposed transition states and resulting products for allylsilane nucleophiles with N-vinyl sulfonamides. 
1.5 DDQ OXIDATIVE CYCLIZATION WITH CATALYTIC DDQ 
Although DDQ was found to be a capable oxidant in the oxidative cyclization reaction 
developed, the use of stoichiometric amounts of DDQ is not without its problems.  The reduced 
product, 2,3-dichloro-5,6-dicyano-1,4-hydroquinone (DDQH), can be difficult to remove.  
Additionally, DDQ poses toxicity concerns with an LD50 of 82 mg/kg
46
 and is capable of 
generating HCN when exposed to moisture.  Additionally, DDQ is moderately expensive, with a 
cost of $624.25/mol from Sigma-Aldrich
47
 at the time of writing this document.  Because of 
these concerns, a reaction catalytic in DDQ in which DDQ is regenerated through oxidation of 
DDQH was an attractive prospect. 
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 A number of ways have been developed to oxidize DDQH to DDQ, including the use of 
H5IO6,
48
 concentrated nitric acid,
49
 FeCl3,
50
 and Mn(OAc)3.
51
  Studies had previously been done 
by Dr. Liu in our group to make the DDQ-mediated oxidative cyclization of allylic and benzylic 
ethers catalytic in DDQ.
52
  He discovered that the addition of 0.15 equiv. of DDQ in three equal 
portions over 24-48 h to the precursor (1 equiv.), 2,6-dichloropyridine (2 equiv.), and MnO2 (6 
equiv.) as the terminal oxidant all in MeNO2 (~0.1 M concentration of precursor) performed the 
desired cyclization reaction in comparable yield to stoichiometric DDQ. 
Initially the conditions developed by Dr. Liu were tested with the N-vinyl carbamate and 
a tethered enol acetate nucleophile.  After 48 h, all starting material was consumed.  However, it 
was found that desired piperidinone 1.46 was obtained as the minor product, with saturated 
piperidinone 1.89 obtained as the major product (Scheme 19).  This was believe to occur due to  
acidity increasing in the reaction mixture as the reaction progressed, generating the N-
acyliminium ion through protonation of the N-vinyl carbamate, and allowing for attack from the 
nucleophile. 
 
Scheme 19: Initial results for the catalytic DDQ oxidative cyclization reaction. 
We next chose to test Mn(OAc)3.  This compound commercially is, however, more 
expensive than DDQ at $987.95/mol
47
 and must be used in large excess, but it can be synthesized 
from less expensive Mn(OAc)2·4H2O ($13.73/mol), acetic acid, and KMnO4.
53
  With this 
oxidant, 2,6-dichloropyridine was no longer a necessary additive.  Adding 0.15 equiv. of DDQ in 
three equal portions over 24 h to enol acetate 1.45 (1 equiv.), 4 Å mol. sieves (1 mass equiv.), 
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and Mn(OAc)3 (3 equiv.) all in MeNO2 (~0.1 M concentration of 1.45) provided desired 
piperidinone 1.46 in 67% yield.  The yield was increased to 75% by adding the DDQ (0.15 
equiv.) to the reaction mixture in one portion and using 6 equiv. of Mn(OAc)3.  No reaction was 
observed prior to DDQ addition.  The mechanism for the proposed DDQ regeneration is shown 
in Scheme 20. 
 
Scheme 20: Proposed mechanism for oxidation of DDQH to DDQ by Mn(OAc)3. 
1.6 SUMMARY 
The DDQ-mediated oxidative cyclization chemistry that was developed for allylic and 
benzylic ethers has been expanded for use with enamides, N-vinyl carbamates, and N-vinyl 
sulfonamides.  This chemistry provides a new method to access N-acyliminium and N-
sulfonyliminium ions.  Cyclization onto the oxidatively generated α,β-unsaturated N-
acyliminium and N-sulfonyliminium ions has been performed with a variety of tethered 
nucleophiles.  The cyclization reaction suffers no difficulties in regards to chemoselectivity or 
overoxidation.  Moreover, the resulting unit of unsaturation in the products provides an 
additional synthetic handle not generated through more classical iminium ion chemistry. 
Significantly, stereocontrol in the reaction was achieved through the use of (E)- and (Z)-
allylsilanes and silyl enol ethers.  Transition state models were formulated through information 
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obtained from studies of the monocyclic and bicyclic compounds synthesized through the 
oxidative cyclization reaction. 
Finally, the reaction was made catalytic through regeneration of DDQ via oxidation of 
the DDQ byproduct by Mn(OAc)3.  This chemistry provides a powerful new method for 
generating nitrogen heterocycles and will provide new ways of accessing alkaloids. 
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APPENDIX A: EXPERIMENTAL PROCEDURES 
General Experimental 
Proton (
1
H NMR) and carbon (
13
C NMR) nuclear magnetic resonance spectra were recorded on a 
Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, respectively, a Bruker Avance 400 
spectrometer at 400 MHz and 100 MHz, respectively, or a Bruker Avance 500 spectrometer at 
500 MHz and 125 MHz, respectively.  The chemical shifts are given in parts per million (ppm) 
on the delta (δ) scale.  The solvent peak was used as a reference value, for 1H NMR: CDCl3 = 
7.26 ppm, C6D6 = 7.16 ppm, for 
13
C NMR: CDCl3 = 77.23 ppm, C6D6 = 128.06 ppm.  Data are 
reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; dd = doublet of doublets; dt 
= doublet of triplets; td = triplet of doublets; tt = triplet of triplets; ddd = doublet of doublet of 
doublets, ddt = doublet of doublet of triplets; dtd = doublet of triplet of doublets; br = broad).  
High resolution mass spectra were recorded on a VG 7070 spectrometer.  Infrared (IR) spectra 
were collected on a Mattson Cygnus 100 spectrometer.  Samples for IR were prepared as a thin 
film on NaCl plate by dissolving the compound in CH2Cl2 and then evaporating the solvent.  
Methylene chloride was distilled under N2 from CaH2.  Nitromethane was purchased from Sigma 
Aldrich, stored over 4 Å mol. sieves, and used without further purification.  DDQ was purchased 
from Sigma Aldrich and used without further purification.  Analytical TLC was performed on E. 
Merck pre-coated (25 mm) silica gel 60F-254 plates.  Visualization was done under UV light 
(254 nm).  Flash chromatography was done using ICN SiliTech 32-63 60Å silica gel.  Reagent 
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grade ethyl acetate, diethyl ether, pentane, and hexanes (commercial mixture) were puchrased 
from EM Science and used for chromatography without further purification.  All reactions were 
performed in oven or flame-dried glassware under a positive pressure of N2 with magnetic 
stirring unless otherwise noted. 
 
General procedure for the cyclization reactions: 
To the substrate (1 equiv.) in nitromethane (~0.1 M substrate concentration) was added activated, 
powdered 4 Å mol. sieves (1 mass equiv.).  Lithium perchlorate (1 equiv.) was added if 
indicated.  The reaction mixture was stirred at room temperature for 5 min., then DDQ (1.2 or 
1.5 equiv.) was added in one portion.  The reaction was monitored by TLC at room temperature 
and usually showed complete consumption of starting material within 3 min.  Upon completion, 
the reaction mixture was quenched with a few drops of NEt3 and directly purified by silica gel 
chromatography to give the desired cyclized product. 
 
General procedure for the construction of the N-vinyl carbamate or N-vinyl sulfonamide 
from the primary alcohol (A): 
To a primary alcohol (1 equiv.) in Et2O was added MsCl (1.5 equiv.) followed by Et3N (2.0 
equiv.) dropwise at 0 ˚C.  The reaction mixture was stirred at room temperature for 30 min.  The 
resulting salts were filtered off, and the reaction mixture was concentrated on a rotary 
evaporator.  The crude mesylate was dissolved in DMF, then NaN3 (1.2 equiv.) was added and 
the reaction mixture was stirred at 70 ˚C for 2 h.  The reaction mixture was quenched with water 
and extracted with Et2O (4x).  The combined organic layers were washed with water and brine, 
dried over MgSO4, then concentrated to ~0.1 M based on starting alcohol.  To the crude azide in 
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Et2O was added LiAlH4 (1.0 M in Et2O, 1.0 equiv.) dropwise at 0 ˚C.  The reaction mixture was 
stirred at 0 ˚C for 30 min., then quenched with H2O dropwise until gas evolution ceased.  The 
reaction mixture was filtered through a plug of Celite.  To the crude amine in Et2O was added the 
appropriate chloroformate or sulfonyl chloride (1.2 equiv.), followed by NEt3 (1.2 equiv.) 
dropwise at 0 ˚C.  The reaction mixture was stirred at room temperature until complete 
consumption of starting material was observed by TLC, then filtered, concentrated, and purified 
by silica gel chromatography (hexanes/EtOAc eluent).  The purified carbamate was dissolved in 
benzene, then heptanal and catalytic PTSA or PPTS added.  The reaction mixture was stirred at 
reflux overnight in a Dean-Stark apparatus.  The reaction mixture was quenched with a few 
drops of NEt3, concentrated on a rotary evaporator, and purified by silica gel chromatography 
(hexanes/EtOAc eluent) to yield the N-vinyl carbamate or sulfonamide.  For some compounds, it 
was necessary to stir the product with NaBH4 (1 equiv.) in EtOH to reduce an inseparable 
impurity that presumably arises from the aldehyde.  The reduced impurity was then removed by 
silica gel chromatography. 
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Procedure for silyl enol ether formation:
i
 
To NaBr (1.6 equiv.) in DMF was added TBSCl, and the mixture was stirred for 20 min.  To the 
solution was added aldehyde 1.42 (1 equiv.) in DMF (~0.1M final substrate concentration), 
followed by NEt3 (1.6 equiv.).  After stirring at room temperature overnight, an additional 1 
equiv. of both TBSCl and NEt3 was added.  The reaction mixture was stirred at room 
temperature for an additional 24 h, then was concentrated and was columned (4:1 
hexanes:EtOAc) to give 174.2 mg of the silyl enol ether as a clear oil in 61% yield and as a 1:2.4 
mixture of E:Z isomers.  The isomers were separated with an AnaLogix IntelliFlash 280 MPLC.  
174.2 mg of the mixture was loaded onto a Varian SF-40g column.  A gradient of 20% to 60% 
DCM in hexanes was used over 40 min. followed by an EtOAc flush of the column.  4 mL 
fractions were collected. 
 
Ethyl (E)-hept-1-en-1-yl((E)-5-((triethylsilyl)oxy)pent-4-en-1-yl)carbamate 
(1.43) 
1
H NMR (400 MHz, CDCl3, two rotamers) δ 6.85 (d, J = 14.0 Hz, 0.5H), 6.71 (d, J = 13.7 Hz, 
0.5H), 6.26 (dt, J = 11.9, 1.2 Hz, 1H), 4.98 (dt, J = 11.9, 7.4 Hz, 1H), 4.83 (dt, J = 14.2, 7.0 Hz, 
1H), 4.19 (q, J = 7.1 Hz, 2H), 3.55 – 3.38 (m, 2H), 2.07 – 1.97 (m, 2H), 1.90 (dt, J = 7.2, 7.2 Hz, 
2H), 1.63 – 1.1.50 (m, 2H), 1.41 – 1.24 (m, 6H), 1.28 (t, J = 6.9 Hz, 3H), 0.97 (t, J = 7.9 Hz, 
9H), 0.88 (t, J = 6.8 Hz, 3H), 0.66 (q, J = 7.9 Hz, 6H); 
13
C NMR (100 MHz, CDCl3, two 
rotamers) δ 154.38 (app. d, J = 59.7 Hz), 140.72, 126.77 (app. d, J = 61.9 Hz), 110.59, 109.57, 
62.01 (app. d, J = 8.7 Hz), 43.66 (app. d, J = 27.2 Hz), 31.53, 30.59, 30.35, 27.85 (app. d, J = 
41.5 Hz), 25.05, 22.74, 14.82, 14.28, 6.73, 4.62; IR (neat) 2956, 2927, 2877, 1710, 1662, 1463, 
                                                 
i Silylenol ether formation: Saeed, A.; Kahn, M. A.; Iqbal, J., Syn. Comm., 1988, 18, 1679-1684. 
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1412, 1324, 1258, 1165, 1013, 946 cm
-1
; HRMS (APCI) m/z calcd for C21H42NO3Si (M + H)
+
 
384.2934, found 384.2943. 
 
Ethyl (E)-hept-1-en-1-yl((Z)-5-((triethylsilyl)oxy)pent-4-en-1-yl)carbamate 
(1.44) 
1
H NMR (400 MHz, CDCl3, two rotamers) δ 6.84 (d, J = 14.3 Hz, 0.5H), 6.71 
(d, J = 13.9 Hz, 0.5H), 6.21 (d, J = 5.8 Hz, 1H), 4.85 (dt, J = 14.1, 6.9 Hz, 1H), 4.45 (td, J = 6.7, 
6.4 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 3.55 – 3.39 (m, 2H), 2.10 (td, J = 7.1, 6.8 Hz, 2H), 2.05 – 
1.95 (m, 2H), 1.58 (br s, 2H), 1.40 – 1.23 (m, 6H), 1.27 (t, J = 7.0 Hz, 3H), 0.97 (t, J = 7.9 Hz, 
9H), 0.87 (t, J = 6.7 Hz, 3H), 0.64 (q, J = 7.9 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) δ 154.31 
(app. d, J = 72.0 Hz), 139.14, 126.79 (app. d, J = 61.6 Hz), 109.65, 109.36, 61.89 (app. d, J = 
11.0 Hz), 43.89 (app. d, J = 14.6 Hz), 31.52, 30.54, 30.35, 27.10 (app. d, J = 52.9 Hz), 22.72, 
21.19, 14.77, 14.25, 6.70, 4.63; IR (neat) 3030, 2957, 2928, 2877, 1711, 1659, 1463, 1412, 1326, 
1277, 1187, 1104, 1068, 1014, 948 cm
-1
; HRMS (APCI) m/z calcd for C21H42NO3Si (M + H)
+
 
384.2934, found 384.2967. 
 
(E)-4-((Ethoxycarbonyl)(hept-1-en-1-yl)amino)but-1-en-2-yl acetate (1.45) 
1
H NMR (300 MHz, CDCl3, two rotamers) δ 6.84 (d, J = 14.7 Hz, 0.5H), 6.69 
(d, J = 14.0 Hz, 0.5H), 4.93 – 4.70 (m, 3H), 4.20 (q, J = 7.1 Hz, 2H), 3.67 (br s, 
2H), 2.45 (br s, 2H), 2.15 (s, 3H), 2.03 (dt, J = 6.9, 6.6 Hz, 2H), 1.44 – 1.22 (m, 6H), 1.29 (t, J = 
7.06Hz, 3H), 0.89 (t, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3, two rotamers) δ 169.22, 
154.13 (app. d, J = 48.5 Hz), 153.55, 126.37 (app. d, J = 52.5 Hz), 109.76 (app. d, J = 17.2 Hz), 
103.20, 62.20 (app. d, J = 12.1), 41.64 (app. d, J = 16.2), 31.47, 31.16, 30.46, 30.28, 22.71, 
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21.27, 14.74, 14.27; IR (neat) 2958, 2927, 2856, 1760, 1710, 1663, 1465, 1260, 1323, 1202, 
1108, 1044, 1019, 949, 881 cm
-1
; HRMS (ESI) m/z calcd for C16H27NO4Na (M + Na)
+
 320.1838, 
found 320.1837. 
 
(E)-Ethyl 2-(hex-1-en-1-yl)-4-oxopiperidine-1-carboxylate (1.46) 
The general cyclization reaction procedure was followed with 1.45 (37.5 mg, 
0.126 mmol, 1.0 equiv.), 4 Å mol. sieves (37.5 mg), and DDQ (42.9 mg, 0.189 
mmol, 1.5 equiv.) in nitromethane (1.2 mL).  The reaction was stirred for 3 min. and was 
quenched with a few drops of NEt3.  The reaction mixture was directly purified by flash 
chromatography (1:1 hexanes:DCM) to yield the desired product (26.1 mg, 82%) as a faint 
yellow oil.  
1
H NMR (300 MHz, CDCl3) δ 5.58 (tdt, J = 15.7, 6.8, 1.4 Hz, 1H), 5.36 (dd, J = 
15.6, 4.7 Hz, 1H), 5.16 (br s, 1H), 4.28 – 4.15 (m, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.33 (ddd, J = 
13.7, 11.0, 4.2 Hz, 1H), 2.67 (dd, J = 14.9, 6.7 Hz, 1H), 2.52 (d, J = 5.0 Hz, 1H), 2.50 – 2.39 (m, 
1H), 2.38 – 2.27 (m, 1H), 2.02 (td, J = 7.1, 6.7 Hz, 2H), 1.38 – 1.22 (m, 4H), 1.29 (t, J = 7.1 Hz, 
3H), 0.87 (t, J = 6.9 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 207.83, 155.66, 134.67, 127.76, 
62.06, 52.95, 44.39, 40.77, 39.05, 32.23, 31.37, 22.36, 14.87, 14.09; IR (neat) 2959, 2928, 2872, 
1719, 1700, 1465, 1420, 1311, 1239, 1173, 1107, 1033, 977 cm
-1
; HRMS (ESI) m/z calcd for 
C14H24NO3 (M + H)
+
 254.1756, found 254.1751. 
 
Catalytic method 
To 1 (37.9 mg, 0.127 mmol, 1.0 equiv.) in MeNO2 (1.5 mL) was added activated 4 Å mol. sieves 
(40.0 mg) and Mn(OAc)3 (205.0 mg, 0.765 mmol, 6.0 equiv.).  DDQ (4.3 mg, 0.019 mmol, 0.15 
equiv.) was added in one portion, and the reaction mixture was stirred at room temperature for 24 
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h.  The reaction was quenched with a drop of NEt3 and was directly purified by flash 
chromatography (3:1 to 2:1 hexanes:EtOAc) to yield the desired product (24.3 mg, 75%) as a 
faint yellow oil. 
 
Ethyl (E)-hept-1-en-1-yl((E)-6-(trimethylsilyl)hex-4-en-1-yl)carbamate 
(1.47) 
1
H NMR (300 MHz, CDCl3, two rotamers) δ 6.85 (d, J = 15.1 Hz, 0.5H), 6.72 (d, J = 13.5 Hz, 
0.5H), 5.42 (dt, J = 15.1, 7.9 Hz, 1H), 5.24 (dt, J = 15.1, 6.6 Hz, 1H), 4.84 (dt, J = 14.2, 7.1 Hz, 
1H), 4.19 (q, J = 7.1 Hz, 2H), 3.47 (br s, 2H), 2.08 – 1.93 (m, 4H), 1.65 – 1.52 (m, 2H), 1.44 – 
1.21 (m, 8H), 1.29 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 6.6 Hz, 3H), -0.02 (s, 9H); 
13
C NMR (100 
MHz, CDCl3, 305K) δ 154.17, 127.92, 127.13, 126.66, 109.57, 61.95, 43.86, 31.52, 30.55, 30.38, 
30.35, 27.31, 22.85, 22.72, 14.81, 14.24, -1.77; IR (neat) 2955, 2928, 2856, 1711, 1661, 1411, 
1324, 1249, 1192, 1154, 1105, 1048, 1023, 947, 850 cm
-1
; HRMS (EI) m/z calcd for 
C19H37NO2Si (M
+
) 339.2594, found 339.2590. 
 
Ethyl trans-2-((E)-hex-1-en-1-yl)-3-vinylpiperidine-1-carboxylate (1.48) 
The general cyclization reaction procedure was followed with 1.47 (100.0 mg, 
0.2945 mmol, 1.0 equiv.), 4 Å mol. sieves (100.0 mg), and DDQ (100.3 mg, 0.4418 mmol, 1.5 
equiv.) in nitromethane (3.0 mL).  The reaction was stirred for 3 min and was quenched with a 
few drops of NEt3.  The reaction mixture was directly purified by flash chromatography (10:1 to 
2:1 hexanes:EtOAc) to yield the desired product (dr > 20:1, 50.4 mg, 65%) as a faint yellow oil.  
1
H NMR (300 MHz, CDCl3) δ 5.93 (ddd, J = 17.3, 10.5, 6.6 Hz, 1H), 5.59 – 5.40 (m, 2H), 5.13 
(ddd, J = 17.3, 1.5, 1.5 Hz, 1H), 5.08 (ddd, J = 10.5, 1.5, 1.5 Hz, 1H), 4.72 (br s, 1H), 4.14 (q, J 
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= 7.1 Hz, 2H), 3.99 (dd, J = 13.2, 3.6 Hz, 1H), 2.90 (td, J = 12.9, 3.4 Hz, 1H), 2.39 (br s, 1H), 
2.04 (dt, J = 6.8, 5.9 Hz, 2H), 1.87 – 1.62 (m, 2H), 1.60-1.50 (m, 2H), 1.44 – 1.25 (m, 4H), 1.24 
(t, J = 7.1 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 156.56, 140.44, 
132.75, 127.84, 115.06, 61.34, 55.90, 41.23, 39.63, 32.34, 31.64, 24.85, 22.39, 20.64, 14.92, 
14.13; IR (neat) 2931, 2859, 1698, 1424, 1256, 1164, 1104 cm
-1
; HRMS (EI) m/z calcd for 
C16H27NO2 (M
+
) 265.2042, found 265.2034. 
 
Ethyl (E)-hept-1-en-1-yl((Z)-6-(trimethylsilyl)hex-4-en-1-yl)carbamate 
(1.49) 
1
H NMR (300 MHz, CDCl3, two rotamers) δ 6.85 (d, J = 13.4 Hz, 0.5H), 6.72 
(d, J = 12.2 Hz, 0.5H), 5.43 (dt, J = 10.4, 8.5 Hz, 1H), 5.33 – 5.20 (m, 1H), 4.86 (dt, J = 14.6, 7.2 
Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.49 (br s, 2H), 2.09 – 1.91 (m, 4H), 1.68 – 1.55 (m, 2H), 1.46 
(d, J = 8.5 Hz, 2H), 1.42 – 1.20 (m, 6H), 1.29 (t, J = 7.0 Hz, 3H), 0.89 (t, J = 6.6 Hz, 3H), 0.00 
(s, 9H); 
13
C NMR (100 MHz, CDCl3, 305K, two rotamers) δ 154.28 (app. d, J = 51.5 Hz), 
127.14, 126.53, 126.40, 109.47, 61.90, 43.89, 31.48, 30.52, 30.32, 27.27 (app. d, J = 42.4 Hz), 
24.59, 22.68, 18.67, 14.76, 14.20, -1.63; IR (neat) 2955, 2927, 2856, 1711, 1661, 1412, 1325, 
1250, 1191, 1106, 1018, 947, 855 cm
-1
; HRMS (EI) m/z calcd for C19H37NO2Si (M
+
) 339.2594, 
found 339.2584. 
 
Ethyl cis-2-((E)-hex-1-en-1-yl)-3-vinylpiperidine-1-carboxylate (1.50) 
The general cyclization reaction procedure was followed with 1.49 (50.0 mg, 
0.147 mmol, 1.0 equiv.), 4 Å mol. sieves (50.0 mg), and DDQ (50.1 mg, 0.221 
mmol, 1.5 equiv.) in nitromethane (2.0 mL).  The reaction was stirred for 3 min. and was 
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quenched with a few drops of NEt3.  The reaction mixture was directly purified by flash 
chromatography (10:1 to 2:1 hexanes:EtOAc) to yield the desired product (dr = 3.3:1, 35.4 mg 
total, 91%) as a faint yellow oil.  
1
H NMR (300 MHz, CDCl3) δ 5.69 (ddd, J = 17.2, 10.1, 6.7 
Hz, 1H), 5.59 – 5.41 (m, 2H), 5.11 – 4.98 (m, 2H), 4.72 (br s, 1H), 4.21 – 4.06 (m, 2H), 3.98 (d, 
J = 10.7 Hz, 1H), 2.87 (t, J = 11.1 Hz, 1H), 2.41 – 2.29 (m, 1H), 2.02 (dt, J = 6.3, 6.2 Hz, 2H), 
1.76 – 1.60 (m, 2H), 1.55 – 1.40 (m, 2H), 1.39 – 1.20 (m, 4H), 1.25 (t, J = 7.1 Hz, 3H), 0.88 (t, J 
= 7.1 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 156.08, 140.37, 135.07, 123.27, 114.94, 61.36, 
56.68, 43.83, 39.34, 32.45, 31.59, 25.50, 24.93, 22.35, 14.93, 14.10; IR (neat) 2931, 2859, 1698, 
1423, 1257, 1166 cm
-1
; HRMS (ASAP) m/z calcd for C16H28NO2 (M
 
+ H)
+
 266.2120, found 
266.2144. 
 
(E)-Ethyl hept-1-en-1-yl(6-(trimethylsilyl)hex-4-yn-1-yl)carbamate (1.51) 
1
H NMR (300 MHz, CDCl3, two rotamers) δ 6.86 (d, J = 14.1 Hz, 0.5H), 6.72 
(d, J = 15.1 Hz, 0.5H), 4.93 (dt, J = 14.4, 7.1 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.57 (br s, 2H), 
2.23 – 2.13 (m, 2H), 2.03 (td, J = 7.1, 6.8 Hz, 2H), 1.79 – 1.65 (m, 2H), 1.43 (t, J = 2.6 Hz, 2H), 
1.40 – 1.24 (m, 6H), 1.29 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 6.7 Hz, 3H), 0.09 (s, 9H); 13C NMR 
(100 MHz, CDCl3, two rotamers) δ 154.30 (app. d, J = 60.1 Hz), 126.78 (app. d, J = 59.7 Hz), 
109.55, 78.16, 77.82, 61.94, 43.43 (app. d, J = 23.4 Hz), 31.49, 30.55, 30.32, 26.90 (app. d, J = 
42.3 Hz), 22.71, 16.84, 14.77, 14.24, 7.10, -1.89; IR (neat) 3087, 2956, 2856, 2221, 1946, 1709, 
1661, 1412, 1324, 1250, 1188, 1108, 1020, 949, 850 cm
-1
; HRMS (ASAP) m/z calcd for 
C19H36NO2Si (M + H)
+
 338.2515, found 338.2548. 
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(E)-Ethyl 2-(hex-1-en-1-yl)-3-vinylidenepiperidine-1-carboxylate (1.52) 
The general cyclization reaction procedure was followed with 1.51 (35.0 mg, 
0.103 mmol, 1.0 equiv.), 4 Å mol. sieves (35.0 mg), and DDQ (35.3 mg, 0.156 mmol, 1.5 equiv.) 
in nitromethane (1.0 mL).  The reaction was stirred for 3 min. and was quenched with a few 
drops of NEt3.  The reaction mixture was directly purified by flash chromatography (6:1 
hexanes:EtOAc) to yield the desired product (19.8 mg, 73%) as a faint yellow oil.  
1
H NMR (300 
MHz, CDCl3) δ 5.57 (dtd, J = 15.4, 6.6,1.7 Hz 1H), 5.39 (ddt, J = 15.4, 4.1, 1.2 Hz, 1H), 5.26 (br 
s, 1H), 4.76 – 4.62 (m, 2H), 4.15 (m, 2H), 4.05 (d, J = 13.7 Hz, 1H), 2.91 (td, J = 13.0, 3.2 Hz, 
1H), 2.30 – 2.21 (m, 2H), 2.05 (dt, J = 6.9, 6.9 Hz, 2H), 1.75 – 1.64 (m, 1H), 1.63 – 1.50 (m, 
1H), 1.42 – 1.29 (m, 4H), 1.26 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 204.40, 155.77, 133.18, 127.56, 98.07, 74.90, 61.52, 56.26, 39.86, 32.12, 31.54, 25.87, 
25.78, 22.39, 14.88, 14.12; IR (neat) 2928, 2856, 1963, 1701, 1420, 1345, 1264, 1178, 1148, 
1101, 1056, 966, 889, 845, 768 cm
-1
; HRMS (ASAP) m/z calcd for C16H26NO2 (M + H)
+
 
264.1946, found 264.1991. 
 
Ethyl trans-3-formyl-2-((E)-hex-1-en-1-yl)piperidine-1-carboxylate (1.53) 
The general cyclization reaction procedure was followed with 1.43 (8.1 mg, 
0.021 mmol, 1.0 equiv.), 4 Å mol. sieves (10.0 mg), and DDQ (5.8 mg, 0.025 
mmol, 1.2 equiv.) in nitromethane (0.2 mL).  The reaction was stirred for 3 min. and was 
quenched with a few drops of NEt3.  The reaction mixture was directly purified by flash 
chromatography (10:1 to 4:1 hexanes:EtOAc) to yield the desired product (dr = 6.7:1, 5.1 mg 
total, 90%) as a faint yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 9.76 (s, 1H), 5.60 (dt, J = 15.3, 
6.8 Hz , 1H), 5.46 (dd, J = 15.5, 4.9 Hz, 1H), 5.37 (br s, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.96 (d, J 
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= 12.7 Hz, 1H), 2.89 (td, J = 13.0, 3.7 Hz, 1H), 2.44 (br s, 1H), 2.14 (d, J = 13.6 Hz, 1H), 2.07 
(dt, J = 6.7, 6.7 Hz, 2H), 1.74 (tt, J = 13.5, 4.7 Hz, 1H), 1.53 – 1.49 (m, 1H), 1.45 (dt, J = 13.2, 
4.3 Hz, 1H), 1.39 – 1.22 (m, 4H), 1.25 (t, J = 7.1 Hz, 3H), 0.90 (t, J = 6.9 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 203.63, 156.10, 133.88, 126.39, 61.69, 51.63, 50.49, 39.34, 32.28, 31.51, 
22.40, 22.05, 19.62, 14.85, 14.13; IR (neat) 2955, 2930, 2862, 1728, 1695, 1424, 1316, 1253, 
1191, 1122, 1101, 1047, 971 cm
-1
; HRMS (ESI) m/z calcd for C15H25NO3Na (M + Na)
+
 
290.1732, found 290.1734. 
 
Ethyl cis-3-formyl-2-((E)-hex-1-en-1-yl)piperidine-1-carboxylate (1.54) 
The general cyclization reaction procedure was followed with 1.44 (40.1 mg, 
0.105 mmol, 1.0 equiv.), 4 Å mol. sieves (40.0 mg), and DDQ (28.5 mg, 0.125 
mmol, 1.2 equiv.) in nitromethane (1.0 mL).  The reaction was stirred for 3 min. and was 
quenched with a few drops of NEt3.  The reaction mixture was directly purified by flash 
chromatography (10:1 to 4:1 hexanes:EtOAc) to yield the desired product (dr = 2.7:1, 25.7 mg, 
93%) as a faint yellow oil.  
1
H NMR (300 MHz, CDCl3) δ 9.62 (s, 1H), 5.74 – 5.56 (m, 1H), 5.41 
(dd, J = 15.2, 7.0 Hz, 1H), 5.30 (br s, 1H), 4.23 – 4.09 (m, 2H), 4.02 (d, J = 11.9 Hz, 1H), 2.89 
(td, J = 13.2, 2.8 Hz, 1H), 2.56 (dt, J = 12.3, 4.0 Hz, 1H), 1.98 (m, 3H), 1.78 (d, J = 13.1 Hz, 
1H), 1.62 (m, 1H), 1.54 – 1.41 (m, 1H), 1.36 – 1.22 (m, 4H), 1.27 (t, J = 7.1 Hz, 3H), 0.87 (t, J = 
7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 202.05, 155.82, 136.49, 122.91, 61.71, 52.65, 52.17, 
39.66, 32.34, 31.33, 24.66, 22.34, 19.83, 14.90, 14.08; IR (neat) 2930, 2859, 1724, 1696, 1423, 
1256, 1165, 1094, 971 cm
-1
; HRMS (ESI) m/z calcd for C15H25NO3Na (M + Na)
+
 290.1732, 
found 290.1730. 
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(E)-3-(1-(Hept-1-en-1-yl)-5-oxopyrrolidin-2-yl)prop-1-en-2-yl acetate 
(1.61) 
1
H NMR (400 MHz, CDCl3, major regioisomer) δ 6.69 (d, J = 14.7 Hz, 1H), 
4.92 (dt, J = 14.5, 7.1 Hz, 1H), 4.87 – 4.84 (m, 1H), 4.78 (br s, 1H), 4.01 (t, J = 8.5 Hz, 1H), 2.64 
(dd, J = 14.9, 2.3 Hz, 1H), 2.57 – 2.46 (m, 1H), 2.39 – 2.26 (m, 2H), 2.11 (s, 3H), 2.07 – 1.94 
(m, 3H), 1.38 – 1.30 (m, 2H), 1.29 – 1.19 (m, 5H), 0.85 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, 
CDCl3, major regioisomer) δ 172.57, 168.99, 152.51, 121.99, 113.36, 104.80, 54.43, 35.02, 
31.36, 30.37, 29.86, 29.82, 23.03, 22.58, 21.13, 14.15; IR (neat) 2955, 2923, 2854, 1755, 1694, 
1660, 1403, 1368, 1204, 1178, 1018, 953 cm
-1
; HRMS (ESI) m/z calcd for C16H25NO3Na (M + 
Na)
+
 302.1732, found 302.1754. 
 
(E)-3-(1-(Hept-1-en-1-yl)-6-oxopiperidin-2-yl)prop-1-en-2-yl acetate (1.62) 
1
H NMR (300 MHz, CDCl3, major regioisomer) δ 7.21 (d, J = 15.0 Hz, 1H), 
5.03 (dt, J = 14.7, 7.1 Hz, 1H), 4.90 (d, J = 1.7 Hz, 1H), 4.83 – 4.80 (m, 1H), 
3.96 (d, J = 8.7 Hz, 1H), 2.73 (dd, J = 14.7, 2.5 Hz, 1H), 2.53 – 2.43 (m, 2H), 2.36 (dd, J = 14.9, 
10.7 Hz, 1H), 2.17 (s, 3H), 2.14 – 2.03 (m, 3H), 1.97 – 1.72 (m, 2H), 1.43 – 1.22 (m, 7H), 0.89 
(t, J = 6.7 Hz, 3H); 
13
C NMR (75 MHz, CDCl3, major regioisomer) δ 168.88, 168.26, 152.77, 
125.09, 112.46, 104.56, 51.06, 35.53, 32.11, 31.46, 30.63, 30.10, 24.77, 22.65, 21.21, 16.01, 
14.19; IR (neat) 3075, 2927, 2856, 1759, 1649, 1428, 1408, 1369, 1332, 1188, 1092, 1021, 960 
cm
-1
; HRMS (EI) m/z calcd for C17H27NO3 (M
+
) 293.1991, found 293.1989. 
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1-((E)-Hex-1-en-1-yl)-6-((E)-5-(trimethylsilyl)pent-3-en-1-yl)piperidin-2-
one (1.66) 
1
H NMR (300 MHz, CDCl3) δ 7.19 (d, J = 14.8 Hz, 1H), 5.43 (dtt, J = 15.1, 7.9, 1.2 Hz, 1H), 
5.21 (dt, J = 15.0, 6.8 Hz, 1H), 5.01 (dt, J = 14.5, 7.2 Hz, 1H), 3.81 – 3.70 (m, 1H), 2.56 – 2.34 
(m, 2H), 2.16 – 2.01 (m, 3H), 1.99 – 1.87 (m, 2H), 1.85 – 1.67 (m, 4H), 1.59 – 1.45 (m, 1H), 
1.42 (d, J = 8.0 Hz, 2H), 1.39 – 1.26 (m, 4H), 0.89 (t, J = 7.1 Hz, 3H), -0.01 (s, 9H); 13C NMR 
(100 MHz, CDCl3) δ 168.60, 127.94, 127.17, 125.52, 112.56, 53.13, 32.76, 32.23, 31.12, 30.48, 
29.97, 24.87, 22.98, 22.44, 16.25, 14.25, -1.66; IR (neat) 2953, 2927, 2872, 1665, 1650, 1408, 
1330, 1272, 1247, 961, 851; HRMS (ESI) m/z calcd for C19H35NONaSi (M + Na)
+
 344.2386, 
found 344.2387. 
 
1-((E)-Hex-1-en-1-yl)-6-((Z)-5-(trimethylsilyl)pent-3-en-1-yl)piperidin-2-
one (1.69) 
1
H NMR (500 MHz, CDCl3) δ 7.20 (d, J = 14.8 Hz, 1H), 5.46 (dt, J = 10.4, 8.7 
Hz, 1H), 5.24 (dt, J = 10.7, 7.1 Hz, 1H), 5.04 (dt, J = 14.5, 7.1 Hz, 1H), 3.79 – 3.72 (m, 1H), 
2.55 – 2.38 (m, 2H), 2.08 (dt, J = 6.9, 6.9 Hz, 2H), 2.05 – 1.84 (m, 4H), 1.83 – 1.71 (m, 3H), 
1.60 – 1.50 (m, 1H), 1.47 (dd, J = 8.5, 3.4 Hz, 2H), 1.40 – 1.27 (m, 4H), 0.89 (t, J = 7.1 Hz, 3H), 
0.01 (s, 9H); 
13
C NMR (125 MHz, CDCl3) δ 168.45, 127.04, 125.81, 125.50, 112.45, 53.28, 
32.68, 32.17, 30.96, 30.41, 25.06, 24.13, 22.38, 18.82, 16.25, 14.15, -1.56; IR (neat) 3006, 2953, 
2926, 2872, 1664, 1648, 1407, 1330, 1272, 1247, 1178, 852 cm
-1
; HRMS (ESI) m/z calcd for 
C19H35NONaSi (M + Na)
+
 344.2386, found 344.2395. 
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(E)-5-(Hex-1-en-1-yl)hexahydroindolizine-3,7-dione (1.70) 
The general cyclization reaction procedure was followed with 1.61 (5.56:1 ratio 
of desired regioisomer to undesired) (75.8 mg [64.2 mg desired regioisomer], 
0.271 mmol, 1.0 equiv.), 4 Å mol. sieves (75.0 mg), and DDQ (92.4 mg, 0.407 mmol, 1.5 equiv.) 
in nitromethane (2.7 mL).  The reaction was stirred for 3 min. and was quenched with a few 
drops of NEt3.  The reaction mixture was directly purified by flash chromatography (4:1 to 1:1 
hexanes:EtOAc) to yield the desired product (41.7 mg, 77% based on amount of desired starting 
regioisomer) as a faint yellow oil.   
1
H NMR (300 MHz, CDCl3) δ 5.61 (dtd, J = 15.2, 6.8, 1.5 
Hz, 1H), 5.31 (dd, J = 15.5, 5.1 Hz, 1H), 5.16 (t, J = 5.2 Hz, 1H), 4.01 – 3.87 (m, 1H), 2.66 – 
2.44 (m, 5H), 2.40 – 2.29 (m, 1H), 2.23 (dd, J = 13.8, 11.5 Hz, 1H), 2.00 (td, J = 6.8, 6.7 Hz, 
2H), 1.81 – 1.66 (m, 1H), 1.37 – 1.19 (m, 4H), 0.87 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 206.51, 173.57, 135.03, 126.22, 53.03, 49.26, 48.51, 43.95, 32.08, 31.17, 30.10, 25.08, 
22.26, 14.00; IR (neat) 2957, 2925, 2871, 2856, 1716, 1690, 1412, 1360, 1287, 1255, 1230, 1202 
cm
-1
; HRMS (ESI) m/z calcd for C14H22NO2 (M + H)
+
 236.1651, found 236.1632. 
 
(E)-4-(Hex-1-en-1-yl)hexahydro-1H-quinolizine-2,6-dione (1.71) 
The general cyclization reaction procedure was followed with 1.62 (45.5 mg 
[38.6 mg desired regioisomer], 0.153 mmol, 1.0 equiv.), 4 Å mol. sieves (50.0 
mg), and DDQ (52.2 mg, 0.230 mmol, 1.5 equiv.) in nitromethane (1.5 mL).  The reaction was 
stirred for 3 min. and was quenched with a few drops of NEt3.  The reaction mixture was directly 
purified by flash chromatography (4:1 to 1:1 hexanes:EtOAc) to yield the desired product (22.8 
mg, 70% based on amount of desired starting regioisomer) as a faint yellow oil. 
1
H NMR (300 
MHz, CDCl3) δ 5.88 – 5.80 (m, 1H), 5.58 (dtd, J = 15.3, 6.7, 1.7 Hz, 1H), 5.30 (ddt, J = 15.7, 
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4.6, 1.4 Hz, 1H), 3.81 (dt, J = 12.7, 6.3 Hz, 1H), 2.59 (d, J = 4.7 Hz, 2H), 2.46 (t, J = 6.4 Hz, 
2H), 2.36 – 2.31 (m, 2H), 2.11 – 1.95 (m, 3H), 1.93 – 1.81 (m, 1H), 1.81 – 1.68 (m, 1H), 1.67 – 
1.54 (m, 1H), 1.37 – 1.18 (m, 4H), 0.86 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
207.25, 169.67, 135.43, 127.36, 50.45, 49.96, 48.25, 43.76, 33.25, 32.31, 31.33, 29.91, 22.34, 
18.76, 14.06; IR (neat) 2955, 2929, 2870, 1719, 1643, 1440, 1414, 1336, 1181, 1089, 978 cm
-1
; 
HRMS (EI) m/z calcd for C15H23NO2 (M
+
) 249.1729, found 249.1728. 
 
trans-6-((E)-Pent-1-en-1-yl)-7-vinylhexahydro-1H-quinolizin-4(6H)-one 
(1.72) 
The general cyclization reaction procedure was followed with 1.66 (13.0 mg, 0.0404 mmol, 1.0 
equiv.), 4 Å mol. sieves (15.0 mg), and DDQ (13.8 mg, 0.0606 mmol, 1.5 equiv.) in 
nitromethane (0.5 mL).  The reaction was stirred for 3 min. and was quenched with a few drops 
of NEt3.  The reaction mixture was directly purified by flash chromatography (6:1 to 2:1 
hexanes:EtOAc) to yield the desired product (dr > 20:1, 9.7 mg, 97%) as a faint yellow oil. 
1
H 
NMR (300 MHz, C6D6) δ 5.95 – 5.79 (m, 2H), 5.57 (dtd, J = 15.5, 6.8, 1.6 Hz, 1H), 5.38 (dd, J = 
15.6, 5.0 Hz, 1H), 5.28 (ddd, J = 17.4, 1.4, 1.4 Hz, 1H), 5.10 (ddd, J = 10.7, 1.4, 1.4 Hz, 1H), 
3.16 – 3.03 (m, 1H), 2.42 – 2.28 (m, 2H), 2.22 – 2.09 (m, 1H), 1.94 (dt, J = 7.1, 6.0 Hz, 2H), 
1.73 – 1.58 (m, 1H), 1.40 – 1.21 (m, 6H), 1.20 – 1.08 (m, 1H), 1.05 – 0.89 (m, 2H), 0.85 (t, J = 
7.3 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 170.20, 139.97, 132.59, 128.12, 115.29, 52.53, 
51.80, 40.74, 34.73, 33.46, 30.92, 29.26, 24.83, 22.59, 19.23, 13.88; IR (neat) 2930, 2870, 1639, 
1454, 1416, 1344, 1329, 1296, 1182, 966; HRMS (ESI) m/z calcd for C16H26NO (M + H)
+
 
248.2014, found 248.1998. 
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cis-6-((E)-Pent-1-en-1-yl)-7-vinylhexahydro-1H-quinolizin-4(6H)-one 
(1.73) 
The general cyclization reaction procedure was followed with 1.69 (30.0 mg, 
0.0933 mmol, 1.0 equiv.), 4 Å mol. sieves (30.0 mg), and DDQ (31.8 mg, 0.140 mmol, 1.5 
equiv.) in nitromethane (1 mL).  The reaction was stirred for 3 min. and was quenched with a 
few drops of NEt3.  The reaction mixture was directly purified by flash chromatography (6:1 to 
2:1 hexanes:EtOAc) to yield the desired product (dr = 3.3:1, 23.0 mg total, 99%) as a faint 
yellow oil.  
1
H NMR (400 MHz, C6D6) δ 5.83 (t, J = 5.8 Hz, 1H), 5.75 (ddd, J = 15.0, 8.1, 6.8 
Hz, 1H), 5.69 (ddd, J = 17.1, 10.6, 6.3 Hz, 1H), 5.50 (dd, J = 15.3, 6.8 Hz, 1H), 4.99 (ddd, J = 
10.3, 1.6, 1.6 Hz, 1H), 4.96 (ddd, J = 17.3, 1.7, 1.7 Hz, 1H), 3.11 – 2.99 (m, 1H), 2.36 (dtd, J = 
17.1, 4.8, 1.9 Hz, 1H), 2.22 – 2.11 (m, 2H), 1.93 (td, J = 7.6, 6.9 Hz, 2H), 1.47 – 1.20 (m, 7H), 
1.20 – 1.08 (m, 1H), 1.01 – 0.89 (m, 2H), 0.82 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
169.61, 139.95, 135.03, 123.55, 115.03, 53.29, 51.49, 43.20, 34.83, 34.10, 33.48, 30.85, 24.71, 
22.52, 19.29, 13.83; IR (neat) 2930, 2870, 1640, 1439, 1416, 1331, 1278, 1183, 969, 912 cm
-1
; 
HRMS (ASAP) m/z calcd for C16H26NO (M + H)
+
 248.2014, found 248.1014. 
 
(E)-4-(N-(Hept-1-en-1-yl)methylsulfonamido)but-1-en-2-yl acetate (1.74) 
1
H NMR (300 MHz, CDCl3) δ 6.35 (d, J = 14.2 Hz, 1H), 4.95 (dt, J = 14.3, 7.1 
Hz, 1H), 4.85 (d, J = 1.8 Hz, 1H), 4.82 – 4.78 (m, 1H), 3.64 – 3.55 (m, 2H), 2.86 
(s, 3H), 2.58 – 2.50 (m, 2H), 2.16 (s, 3H), 2.03 (dt, 7.1, 6.9 Hz, 2H), 1.43 – 1.22 (m, 6H), 0.88 (t, 
J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 169.27, 152.77, 125.05, 113.38, 103.82, 43.33, 
38.80, 32.07, 31.43, 30.35, 29.97, 22.65, 21.26, 14.24; IR (neat) 3018, 2929, 2856, 1757, 1658, 
1458, 1348, 1154, 1080, 1021, 962, 882, 756 cm
-1
; HRMS (ESI) m/z calcd for C14H25NO4NaS 
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(M + Na)
+
 326.1402, found 326.1382. 
 
(E)-2-(Hex-1-en-1-yl)-1-(methylsulfonyl)piperidin-4-one (1.75) 
The general cyclization reaction procedure was followed with 1.74 (60.0 mg, 
0.198 mmol, 1.0 equiv.), 4 Å mol. sieves (60.0 mg), and DDQ (67.3 mg, 0.297 
mmol, 1.5 equiv.) in nitromethane (2.0 mL).  The reaction was stirred for 3 min. and was 
quenched with a few drops of NEt3.  The reaction mixture was directly purified by flash 
chromatography (2:1 to 1:2 hexanes:EtOAc) to yield the desired product (35.4 mg, 69%) as a 
faint yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 5.73 (dtd, J = 15.0, 6.8, 1.2 Hz, 1H), 5.44 (ddt, J 
= 15.5, 6.7, 1.4 Hz, 1H), 4.90 (t, J = 6.2 Hz, 1H), 3.98 (ddt, J = 13.0, 7.2, 1.9 Hz, 1H), 3.32 (ddd, 
J = 13.0, 12.2, 3.5 Hz, 1H), 2.91 (s, 3H), 2.85 (ddd, J = 14.5, 6.6, 0.6 Hz, 1H), 2.70 – 2.60 (m, 
1H), 2.53 (dt, J = 14.6, 2.0 Hz, 1H), 2.39 (ddt, J = 14.9, 3.7, 2.0 Hz, 1H), 2.04 (dt, J = 7.0, 7.0 
Hz, 2H), 1.37 – 1.22 (m, 4H), 0.88 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 206.25, 
137.23, 125.61, 56.12, 46.09, 41.26, 40.61, 40.15, 32.28, 31.25, 22.40, 14.05; IR (neat) 2958, 
2929, 2872, 1720, 1334, 1225, 1151, 1049, 962 cm
-1
; HRMS (ESI) m/z calcd for C12H21NO3SK 
(M + K)
+
 298.0879, found 298.0905. 
 
N-((E)-Hept-1-en-1-yl)-N-((E)-6-(trimethylsilyl)hex-4-en-1-
yl)methanesulfonamide (1.76) 
1
H NMR (400 MHz, CDCl3) δ 6.36 (d, J = 14.2 Hz, 1H), 5.43 (dtt, J = 15.1, 
8.0, 1.1 Hz, 1H), 5.22 (dt, J = 15.0, 6.8 Hz, 1H), 4.92 (dt, J = 14.2, 7.2 Hz, 1H), 3.40 (dd, J = 7.6, 
7.5 Hz, 2H), 2.83 (s, 3H), 2.02 (dt, J = 7.2, 7.2 Hz, 4H), 1.73 – 1.61 (m, 2H), 1.40 (dd, J = 8.0, 
0.7 Hz, 2H), 1.38 – 1.22 (m, 6H), 0.88 (t, J = 6.9 Hz, 3H), -0.02 (s, 9H); 13C NMR (109 MHz, 
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CDCl3) δ 127.69, 127.30, 125.48, 112.98, 45.53, 38.47, 31.45, 30.40, 30.15, 30.03, 27.63, 22.86, 
22.66, 14.26, -1.77; IR (neat) 3017, 2928, 2856, 1657, 1462, 1350, 1247, 1155, 962, 850 cm
-1
; 
HRMS (ESI) m/z calcd for C17H35NO2NaSSi (M + Na)
+
 368.2055, found 368.2093. 
 
cis-2-((E)-Hex-1-en-1-yl)-3-vinyl-N-(methylsulfonyl)piperidine (1.77) 
The general cyclization reaction procedure was followed with 1.76 (50.0 mg, 
0.145 mmol, 1.0 equiv.), 4 Å mol. sieves (50.0 mg), LiClO4 (15.4 mg, 0.145 mmol, 1.0 equiv.) 
and DDQ (49.3 mg, 0.217 mmol, 1.5 equiv.) in nitromethane (1.5 mL).  The reaction was stirred 
for 3 min. and was quenched with a few drops of NEt3.  The reaction mixture was directly 
purified by flash chromatography (8:1 to 2:1 hexanes:EtOAc) to yield the desired product (dr = 
3.7:1, 32.1 mg total, 82%) as a faint yellow oil.  
1
H NMR (500 MHz, CDCl3) δ 6.06 (ddd, J = 
17.4, 10.5, 6.8 Hz, 1H), 5.81 – 5.71 (m, 2H), 5.18 (ddd, J = 17.4, 1.4, 1.4 Hz, 1H), 5.14 (ddd, J = 
10.5, 1.4, 1.4 Hz, 1H), 4.36 (d, J = 4.5 Hz, 1H), 3.60 (dd, J = 13.8, 3.9 Hz, 1H), 3.03 (td, J = 
12.2, 3.1 Hz, 1H), 2.76 (s, 3H), 2.36 (br s, 1H), 2.11 – 2.05 (m, 2H), 1.89 – 1.79 (m, 2H), 1.67 – 
1.60 (m, 1H), 1.56 – 1.51 (m, 1H), 1.41 – 1.28 (m, 4H), 0.91 (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 139.74, 135.73, 125.54, 115.78, 59.43, 42.45, 41.48, 38.83, 32.38, 31.50, 24.60, 
22.49, 20.99, 14.10; IR (neat) 2954, 2927, 2857, 1455, 1334, 1157, 962, 923 cm
-1
; HRMS 
(ASAP) m/z calcd for C14H26NO2S (M + H)
+
 272.1684, found 272.1694. 
 
N-((E)-Hept-1-en-1-yl)-N-((Z)-6-(trimethylsilyl)hex-4-en-1-
yl)methanesulfonamide (1.78) 
1
H NMR (300 MHz, CDCl3) δ 6.37 (d, J = 14.2 Hz, 1H), 5.45 (dt, J = 10.7, 8.6 
Hz, 1H), 5.25 (dt, J = 10.9, 7.2 Hz, 1H), 4.95 (dt, J = 14.1, 7.1 Hz, 1H), 3.23 (dd, J = 7.8, 7.4 Hz, 
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2H), 2.84 (s, 3H), 2.03 (dt, J = 7.5, 6.8 Hz, 4H), 1.76 – 1.62 (m, 2H), 1.47 (d, J = 8.6 Hz, 2H), 
1.43 – 1.22 (m, 6H), 0.89 (t, J = 6.8 Hz, 3H), 0.00 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
127.03, 125.94, 125.46, 112.99, 45.66, 38.56, 31.49, 30.43, 30.06, 27.52, 24.42, 22.69, 18.79, 
14.28, -1.56; IR (neat) 3007, 2954, 2927, 2856, 1656, 1349, 1322, 1247, 1154, 961, 854 cm
-1
; 
HRMS (ASAP) m/z calcd for C17H36NO2SSi (M + H)
+
 346.2236, found 346.2251. 
 
trans-2-((E)-Hex-1-en-1-yl)-3-vinyl-N-(methylsulfonyl)piperidine (1.79) 
The general cyclization reaction procedure was followed with 1.78 (50.0 mg, 
0.145 mmol, 1.0 equiv.), 4 Å mol. sieves (50.0 mg), LiClO4 (15.4 mg, 0.145 
mmol, 1.0 equiv.) and DDQ (49.3 mg, 0.217 mmol, 1.5 equiv.) in nitromethane (1.5 mL).  The 
reaction was stirred for 3 min. and was quenched with a few drops of NEt3.  The reaction mixture 
was directly purified by flash chromatography (8:1 to 2:1 hexanes:EtOAc) to yield the desired 
product (dr = 2.7:1, 36.5 mg total, 93%) as a faint yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 5.73 
(dt, J = 15.3, 6.5 Hz, 1H), 5.61 (ddt, J = 15.2, 9.1, 1.2 Hz, 1H), 5.56 (ddd, J = 17.4, 10.5, 7.1 Hz, 
1H), 5.04 (ddd, J = 11.7, 1.5, 1.5 Hz, 1H), 5.01 (ddd, J = 4.9, 1.6, 1.6 Hz, 1H), 4.40 (dd, J = 9.0, 
4.9 Hz, 1H), 3.69 – 3.63 (m, 1H), 2.90 (td, J = 12.5, 3.3 Hz, 1H), 2.75 (s, 3H), 2.56 – 2.46 (m, 
1H), 2.07 (td, J = 7.0, 6.9 Hz, 2H), 1.86 – 1.78 (m, 1H), 1.77 – 1.63 (m, 2H), 1.53 – 1.41 (m, 
1H), 1.40 – 1.23 (m, 4H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 139.66, 
138.14, 121.28, 115.47, 59.53, 44.49, 40.78, 38.57, 32.47, 31.49, 25.47, 24.64, 22.46, 14.08; IR 
(neat) 2930, 2858, 1332, 1153, 993, 968, 992 cm
-1
; HRMS (ASAP) m/z calcd for C14H26NO2S 
(M
 
+ H)
+
 272.1684, found 272.1678. 
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(E)-4-(N-(Hept-1-en-1-yl)-4-toluenesulfonamido)but-1-en-2-yl acetate (1.80) 
1
H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 2H), 7.32 – 7.24 (m, 2H), 
6.45 (d, J = 14.2 Hz, 1H), 4.88 – 4.78 (m, 2H), 4.76 – 4.73 (m, 1H), 3.42 (dd, J 
= 7.7, 7.5 Hz, 2H), 2.46 (dd, J = 7.8, 7.5 Hz, 2H), 2.40 (s, 3H), 2.13 (s, 3H), 2.01 (dt, J = 7.2, 7.1 
Hz, 2H), 1.37 – 1.17 (m, 6H), 0.87 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 169.18, 
152.92, 143.77, 136.17, 129.89, 127.07, 125.48, 113.79, 103.54, 43.36, 31.75, 31.29, 30.27, 
29.85, 22.61, 21.69, 21.22, 14.24; IR (neat) 3069, 3030, 2956, 2927, 2856, 1757, 1656, 1598, 
1458, 1354, 1162, 1092, 1020, 948, 814 cm
-1
; HRMS (ESI) m/z calcd for C20H29NO4NaS (M + 
Na)
+
 402.1715, found 402.1740. 
 
(E)-2-(Hex-1-en-1-yl)-1-tosylpiperidin-4-one (1.81) 
The general cyclization reaction procedure was followed with 1.80 (30.0 mg, 
0.0790 mmol, 1.0 equiv.), 4 Å mol. sieves (30.0 mg), and DDQ (26.9 mg, 0.119 
mmol, 1.5 equiv.) in nitromethane (0.7 mL).  The reaction was stirred for 3 min. and was 
quenched with a few drops of NEt3.  The reaction mixture was directly purified by flash 
chromatography (8:1 to 4:1 hexanes:EtOAc) to yield the desired product (16.9 mg, 64%) as a 
faint yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.4 Hz, 
2H), 5.53 (dtd, J = 15.2, 6.7, 1.5 Hz, 1H), 5.16 (dd, J = 15.6, 5.3 Hz, 1H), 4.94 (t, J = 5.0 Hz, 
1H), 4.02 (ddt, J = 13.4, 7.1, 2.0 Hz, 1H), 3.28 (ddd, J = 13.4, 12.1, 3.6 Hz, 1H), 2.66 (dd, J = 
14.7, 6.6 Hz, 1H), 2.54 – 2.45 (m, 2H), 2.43 (s, 3H), 2.33 – 2.24 (m, 1H), 1.90 (td, J = 7.0, 6.8 
Hz, 2H), 1.24 – 1.16 (m, 4H), 0.84 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 206.47, 
143.92, 137.49, 136.28, 130.04, 127.40, 126.04, 55.36, 45.06, 40.80, 40.58, 32.12, 31.07, 22.30, 
21.74, 14.05; IR (neat) 2957, 2928, 2872, 1721, 1598, 1458, 1343, 1225, 1343, 1225, 1159, 
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1095, 1047, 980, 927 cm
-1
; HRMS (ESB) m/z calcd for C18H25NO3NaS (M + Na)
+
 358.1453, 
found 358.1437. 
 
N-((E)-Hept-1-en-1-yl)-N-((E)-6-(trimethylsilyl)hex-4-en-1-
yl)toluenesulfonamide (1.82) 
1
H NMR (300 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 2H), 7.27 (d, J = 7.8 Hz, 
2H), 6.47 (d, J = 14.2 Hz, 1H), 5.39 (dt, J = 15.6, 7.9 Hz, 1H), 5.19 (dt, J = 14.8, 6.6 Hz, 1H), 
4.81 (dt, J = 14.2, 7.2 Hz, 1H), 3.23 (m, J = 7.6, 7.4 Hz, 2H), 2.41 (s, 3H), 2.08 – 1.93 (m, 4H), 
1.65 – 1.54 (m, 2H), 1.39 (d, J = 7.8 Hz, 2H), 1.37 – 1.18 (m, 6H), 0.88 (t, J = 6.9 Hz, 3H), -0.03 
(s, 9H); 
13
C NMR (125 MHz, CDCl3) δ 143.47, 136.44, 129.80, 127.48, 127.46, 127.10, 125.92, 
113.44, 45.49, 31.36, 30.37, 30.20, 29.95, 27.33, 22.84, 22.68, 21.73, 14.31, -1.77; IR (neat) 
3017, 2953, 2928, 2857, 1656, 1598, 1458, 1404, 1354, 1247, 1163, 1093, 965, 850 cm
-1
; HRMS 
(ESI) m/z calcd for C23H40NO2SSi (M + H)
+
 422.2549, found 422.2545. 
 
(E)-2-(Hex-1-en-1-yl)-1-tosyl-3-vinylpiperidine (1.83) 
The general cyclization reaction procedure was followed with 1.82 (50.0 mg, 
0.119 mmol, 1.0 equiv.), 4 Å mol. sieves (50.0 mg), LiClO4 (12.6 mg, 0.119 
mmol, 1.0 equiv.) and DDQ (40.4 mg, 0.178 mmol, 1.5 equiv.) in nitromethane (1.2 mL).  The 
reaction was stirred for 3 min. and was quenched with a few drops of NEt3.  The reaction mixture 
was directly purified by flash chromatography (8:1 to 2:1 hexanes:EtOAc) to yield the desired 
product (dr = 4.0:1 cis:trans, 30.7 mg total, 75%) as a faint yellow oil.  
1
H NMR (500 MHz, 
CDCl3, two diastereomers 1:0.25 ratio) δ 7.65 – 7.61 (m, 2.5H), 7.23 (d, J = 8.0 Hz, 2.5H), 6.02 
(ddd, J = 17.5, 10.5, 7.1 Hz, 1H), 5.56 (ddd, J = 10.3, 8.4, 5.0 Hz, 0.25H), 5.53 – 5.46 (m, 1H), 
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5.33 (ddt, J = 15.4, 7.2, 1.4 Hz, 1H), 5.23 (ddt, J = 15.3, 8.1, 1.4 Hz, 0.25H), 5.16 (ddd, J = 17.3, 
1.5, 1.5 Hz, 1H), 5.09 (ddd, J = 10.5, 1.4, 1.4 Hz, 1H), 5.02 – 4.99 (m, 0.25H), 4.99 – 4.97 (m, 
0.25H), 4.50 (dd, J = 8.0, 4.8 Hz, 0.25H), 4.41 (d, J = 7.0 Hz, 1H), 3.76 – 3.71 (m, 0.25H), 3.65 
– 3.60 (m, 1H), 2.92 (td, J = 12.2, 3.2 Hz, 1H), 2.84 (td, J = 12.7, 3.0 Hz, 0.25H), 2.40 (s, 
3.75H), 2.33 – 2.28 (m, 1H), 1.89 – 1.81 (m, 2.5H), 1.79 – 1.67 (m, 2.5H), 1.63 – 1.44 (m, 2.5H), 
1.41 – 1.32 (m, 0.5H), 1.28 – 1.14 (m, 5H), 0.87 (t, J = 7.0 Hz, 3H), 0.86 (t, J = 6.9 Hz, 0.75H); 
13
C NMR (125 MHz, CDCl3) δ 142.85, 139.91, 139.86, 137.95, 137.80, 136.77, 134.31, 129.43, 
129.38, 127.78, 127.71, 125.60, 120.95, 115.48, 115.27, 59.32, 59.21, 44.39, 42.92, 41.71, 40.95, 
32.20, 32.14, 31.21, 25.32, 24.66, 24.61, 22.42, 22.39, 21.64, 20.98, 14.12, 14.09; IR (neat) 
2953, 2929, 2859, 1454, 1339, 1162, 1092, 968, 924, 814 cm
-1
; HRMS (ESI) m/z calcd for 
C20H29NO2NaS (M + Na)
+
 370.1817, found 370.1830. 
 
trans-2-((E)-Hex-1-en-1-yl)-3-vinyl-N-methylpiperidine (1.87) 
To 1.48 (12.3 mg, 0.0463 mmol, 1.0 equiv.) in anhydrous THF under argon was 
added 1M LiAlH4 in Et2O (0.0926 mL, 0.0926 mmol, 2.0 equiv.). The reaction mixture was 
stirred at 80 ˚C for 2 h then was quenched with water.  The crude mixture was filtered through a 
plug of Celite, was concentrated, then was purified twice by flash chromatography (100:5:1 
EtOAc:MeOH:NH4OH then 10:1 DCM:MeOH) to yield the product (7.8 mg, 81%) as a faint 
yellow oil.  
1
H NMR (500 MHz, C6D6) δ 5.72 (ddd, J = 17.2, 10.6, 7.7 Hz, 1H), 5.44 (dt, J = 
15.4, 6.5 Hz, 1H), 5.35 (dd, J = 15.5, 8.6 Hz, 1H), 5.00 – 4.93 (m, 2H), 2.84 – 2.77 (m, 1H), 2.24 
(s, 3H), 2.19 – 2.09 (m, 1H), 2.25 (dd, J = 9.0, 8.6 Hz, 1H), 1.96 (dt, J = 6.7, 6.7 Hz, 2H), 1.86 
(td, J = 11.7, 2.6 Hz, 1H), 1.76 – 1.65 (m, 2H), 1.50 – 1.44 (m, 1H), 1.33 – 1.22 (m, 4H), 1.12 
(ddd, J = 25.6, 13.2, 4.4 Hz, 1H), 0.85 (t, J = 7.1 Hz, 3H); 
13
C NMR (125 MHz, C6D6) δ 142.27, 
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133.59, 132.95, 114.02, 72.80, 56.54, 46.16, 44.63, 32.33, 31.94, 31.13, 25.53, 22.55, 14.10; IR 
(neat) 2928, 2853, 2776, 1459, 1373, 1110, 972 cm
-1
; HRMS (ASAP) m/z calcd for C14H26N (M
 
+ H)
+
 208.2065, found 208.2068. 
 
trans-2-((E)-Hex-1-en-1-yl)-3-vinyl-N-methylpiperidine (1.88) 
To 1.50 (18.3 mg, 0.0690 mmol, 1.0 equiv.) in anhydrous THF under argon was 
added 1 M LiAlH4 in Et2O (0.138 mL, 0.138 mmol, 2.0 equiv.). The reaction mixture was stirred 
at 60 ˚C for 4 h then was quenched with water.  The crude mixture was filtered through a plug of 
Celite, was concentrated, then was purified twice by flash chromatography (100:5:1 
EtOAc:MeOH:NH4OH then 10:1 DCM:MeOH) to yield the product (12.2 mg, 85%) as a faint 
yellow oil.  
1
H NMR (300 MHz, C6D6) δ 6.28 – 6.09 (m, 1H), 5.54 (dd, J = 15.3, 8.9 Hz, 1H), 
5.43 (dt, J = 15.3, 6.3 Hz, 1H), 5.10 – 4.99 (m, 2H), 2.75 (dd, J = 8.9, 3.4 Hz, 1H), 2.62 - 2.52 
(m, 1H), 2.49 (br s, 1H), 2.19 (s, 3H), 2.11 (ddd, J = 11.3, 7.9, 3.2 Hz, 1H), 1.96 (dt, J = 6.7, 6.5 
Hz, 2H), 1.78 - 1.65 (m, 1H), 1.52 - 1.46 (m, 2H), 1.34 – 1.19 (m, 5H), 0.86 (t, J = 7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 140.30, 135.42, 126.29, 114.83, 68.88, 52.73, 45.18, 44.06, 
32.37, 31.78, 27.49, 23.85, 22.34, 14.09; IR (neat) 2928, 2854, 2776, 1553, 1444, 1370, 1112, 
971, 910 cm
-1
; HRMS (ASAP) m/z calcd for C14H26N (M + H)
 +
 208.2065, found 208.2064. 
 
Ethyl but-3-yn-1-ylcarbamate (1.90) 
1
H NMR (300 MHz, CDCl3) δ 4.96 (br s, 1H), 4.12 (q, 7.0 Hz, 2H), 3.33 (dd, J = 12.6, 
6.3 Hz, 2H), 2.40 (td, J = 6.4, 2.6 Hz, 2H), 2.00 (t, J = 2.6 Hz, 1H), 1.24 (t, J =7.1 Hz, 3H). 
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These data are consistent with literature values.
ii
 
 
(E)-Ethyl but-3-yn-1-yl(hept-1-en-1-yl)carbamate (1.91) 
1
H NMR (400 MHz, CDCl3, two rotamers) δ 6.83 (d, J = 14.0 Hz, 0.5H), 6.69 
(d, J = 14.1 Hz, 0.5H), 4.91 (dt, J = 14.4, 7.1 Hz, 1H), 4.21 (q, J = 7.1 Hz, 2H), 3.76 – 3.63 (m, 
2H), 2.44 (br s, 2H), 2.07 – 1.96 (m, 3H), 1.42 – 1.23 (m, 6H), 1.30 (t, J = 7.1 Hz, 3H), 0.89 (t, J 
= 6.7 Hz, 3H); 
13
C NMR (125 MHz, CDCl3, two rotamers) δ 154.00 (app. d, J = 47.9 Hz), 
126.27 (app. d, J = 56.7 Hz), 109.93 (app. d, J = 29.0 Hz), 81.54 (app. d, J = 22.7 Hz), 68.87 
(app. d, J = 16.4 Hz), 62.25 (app. d, J = 12.6 Hz), 42.83 (app. d, J = 36.54 Hz), 31.47, 30.45 (app 
d., J = 12.6 Hz), 30.19, 22.68, 17.01 (app. d, J = 51.7 Hz), 14.73, 14.23; IR (neat) 3310, 2958, 
2927, 2856, 1710, 1662, 1465, 1412, 1322, 1198, 1134, 1110, 1009, 948 cm
-1
, HRMS (ESI) m/z 
calcd for C14H23NO2Na (M + Na)
+
 260.1626, found 260.1635. 
                                                 
ii Paget, S. D.; Weidner-Wells, M. A.; Werblood, H. M., (Ortho-McNeil Pharmaceutical, Inc., US).  
“Pyridoarylphenyl Oxazolidinone Antibacterials, and Related Compositions and Methods” Patent WO 02/064574 
A2, August 22, 2002. 
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